JPH0348798B2 - - Google Patents
Info
- Publication number
- JPH0348798B2 JPH0348798B2 JP61276480A JP27648086A JPH0348798B2 JP H0348798 B2 JPH0348798 B2 JP H0348798B2 JP 61276480 A JP61276480 A JP 61276480A JP 27648086 A JP27648086 A JP 27648086A JP H0348798 B2 JPH0348798 B2 JP H0348798B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell differentiation
- inducing
- human
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004027 cell Anatomy 0.000 claims description 104
- 230000024245 cell differentiation Effects 0.000 claims description 57
- 230000001939 inductive effect Effects 0.000 claims description 49
- 239000000126 substance Substances 0.000 claims description 36
- 230000000694 effects Effects 0.000 claims description 27
- 230000004069 differentiation Effects 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 208000032839 leukemia Diseases 0.000 claims description 15
- 238000001962 electrophoresis Methods 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 9
- 108090001090 Lectins Proteins 0.000 claims description 8
- 102000004856 Lectins Human genes 0.000 claims description 8
- 238000002523 gelfiltration Methods 0.000 claims description 8
- 239000002523 lectin Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000007423 decrease Effects 0.000 claims description 6
- 210000002540 macrophage Anatomy 0.000 claims description 6
- 238000001179 sorption measurement Methods 0.000 claims description 6
- 239000003638 chemical reducing agent Substances 0.000 claims description 5
- 229920002401 polyacrylamide Polymers 0.000 claims description 5
- 108010062580 Concanavalin A Proteins 0.000 claims description 4
- 230000003213 activating effect Effects 0.000 claims description 4
- 108010034897 lentil lectin Proteins 0.000 claims description 4
- 238000013019 agitation Methods 0.000 claims description 3
- 239000000411 inducer Substances 0.000 description 30
- 239000000243 solution Substances 0.000 description 27
- 239000002609 medium Substances 0.000 description 20
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000012258 culturing Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 239000001569 carbon dioxide Substances 0.000 description 9
- 229910002092 carbon dioxide Inorganic materials 0.000 description 9
- DGVVWUTYPXICAM-UHFFFAOYSA-N βâMercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 206010057249 Phagocytosis Diseases 0.000 description 7
- 239000012091 fetal bovine serum Substances 0.000 description 7
- 239000004816 latex Substances 0.000 description 7
- 229920000126 latex Polymers 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 230000008782 phagocytosis Effects 0.000 description 7
- 239000008363 phosphate buffer Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000012980 RPMI-1640 medium Substances 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 210000001539 phagocyte Anatomy 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 108010059712 Pronase Proteins 0.000 description 4
- 208000000389 T-cell leukemia Diseases 0.000 description 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000012228 culture supernatant Substances 0.000 description 4
- 210000005104 human peripheral blood lymphocyte Anatomy 0.000 description 4
- 238000001155 isoelectric focusing Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229930002330 retinoic acid Natural products 0.000 description 4
- 210000000130 stem cell Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 3
- 230000003698 anagen phase Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 101000573199 Homo sapiens Protein PML Proteins 0.000 description 2
- 206010024305 Leukaemia monocytic Diseases 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 229940061607 dibasic sodium phosphate Drugs 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- -1 diterpene compounds Chemical class 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N glutamic acid Chemical compound OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 229960002885 histidine Drugs 0.000 description 2
- 102000054896 human PML Human genes 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 201000006894 monocytic leukemia Diseases 0.000 description 2
- 208000025113 myeloid leukemia Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 150000004633 phorbol derivatives Chemical class 0.000 description 2
- 239000002644 phorbol ester Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000004017 serum-free culture medium Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HOVAGTYPODGVJG-BWSJPXOBSA-N (2r,3s,4s,5s)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-BWSJPXOBSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 206010000871 Acute monocytic leukaemia Diseases 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 102100023336 Chymotrypsin-like elastase family member 3B Human genes 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 241000219739 Lens Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000035489 Monocytic Acute Leukemia Diseases 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- OOYGSFOGFJDDHP-KMCOLRRFSA-N kanamycin A sulfate Chemical compound OS(O)(=O)=O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N OOYGSFOGFJDDHP-KMCOLRRFSA-N 0.000 description 1
- 229960002064 kanamycin sulfate Drugs 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- HOVAGTYPODGVJG-VEIUFWFVSA-N methyl alpha-D-mannoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-VEIUFWFVSA-N 0.000 description 1
- DLEDLHFNQDHEOJ-CSWXFLMBSA-N mezerein Chemical compound O([C@@H]1[C@H]([C@@]23[C@H]4[C@](C(C(C)=C4)=O)(O)[C@H](O)C4(CO)O[C@H]4[C@H]3[C@H]3OC(O2)(O[C@]31C(C)=C)C=1C=CC=CC=1)C)C(=O)\C=C\C=C\C1=CC=CC=C1 DLEDLHFNQDHEOJ-CSWXFLMBSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 108010043524 protease E Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229960002385 streptomycin sulfate Drugs 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
ãç£æ¥äžã®å©çšåéã
æ¬çºæã¯æ°èŠãªçç掻æ§ç©è³ªã®è£œé æ¹æ³ã«é¢ã
ããã®ã§ãããæŽã«è©³ããã¯ãããç±æ¥ã®çœè¡ç
现èãå¹é€ããããšã«ãã€ãŠç£çãããã现èå
åèªå°äœçšãæããèçœæ§ã®ããç±æ¥ã®çç掻æ§
ç©è³ªïŒä»¥äžã现èååèªå°ç©è³ªãšç¥èšïŒã®è£œé æ³
ã«é¢ãããã®ã§ããã
ããã®ã§ãããæŽã«è©³ããã¯ãããç±æ¥ã®çœè¡ç
现èãå¹é€ããããšã«ãã€ãŠç£çãããã现èå
åèªå°äœçšãæããèçœæ§ã®ããç±æ¥ã®çç掻æ§
ç©è³ªïŒä»¥äžã现èååèªå°ç©è³ªãšç¥èšïŒã®è£œé æ³
ã«é¢ãããã®ã§ããã
å
ç«åå¿ãã€ããã©ã€ãŠãã现è矀ã®äžã§ãæ
è¿ãã¯ããã¢ãŒãžïŒä»¥äžÎÏãšç¥ãïŒã泚ç®ãã
ãããã«ãªã€ãŠãããÎÏããã©ãé£äœçšã«ãã
æåã®åŠçãå§ããšããŠãçäœã®é²åŸ¡æ©æ§ã®äž
ã§ãäžå¿çãªåœ¹å²ãæŒããŠããããšããæããã«
ãªã€ãŠããããã§ããããŸãã现èå€ããã®åºæ¿
ã«å¿ããŠãÎÏããã€ã³ã¿ãŒãã€ãã³âïŒãçå£
æ»å åãã³ãããŒåœ¢æåºæ¿å åãªã©ãå€çš®ã®éèŠ
ãªçç掻æ§ç©è³ªãç£çããããšãç¥ãããŠããã
è¿ãã¯ããã¢ãŒãžïŒä»¥äžÎÏãšç¥ãïŒã泚ç®ãã
ãããã«ãªã€ãŠãããÎÏããã©ãé£äœçšã«ãã
æåã®åŠçãå§ããšããŠãçäœã®é²åŸ¡æ©æ§ã®äž
ã§ãäžå¿çãªåœ¹å²ãæŒããŠããããšããæããã«
ãªã€ãŠããããã§ããããŸãã现èå€ããã®åºæ¿
ã«å¿ããŠãÎÏããã€ã³ã¿ãŒãã€ãã³âïŒãçå£
æ»å åãã³ãããŒåœ¢æåºæ¿å åãªã©ãå€çš®ã®éèŠ
ãªçç掻æ§ç©è³ªãç£çããããšãç¥ãããŠããã
è¡æ¶²çŽ°èã¯ãé è¡å¹¹çŽ°èãããå¢æ®ååãç¹°ã
è¿ããæçããŠæ©èœçŽ°èãžå°éããã®ã§ãããã
ã®ååæçã®éçšã§å¢æ®èœããã¡ãè «ããåããŠ
ããŸã€ããã®ãçœè¡ç 现èã§ããããã®ãããªè «
ãã现èãæ£åžžãªæ©èœããã€ã现èãžãšååãèª
å°ããã®ããååèªå°èœããã€ãç©è³ªã§ãããã
ããååèªå°èœããã€ãç©è³ªãçšããããšã«ã
ããæ°ããçã®æ²»çæ¹æ³ãéçºã§ãããã®ãšã
ãŠãè¿å¹Žã泚ç®ãããŠããã
è¿ããæçããŠæ©èœçŽ°èãžå°éããã®ã§ãããã
ã®ååæçã®éçšã§å¢æ®èœããã¡ãè «ããåããŠ
ããŸã€ããã®ãçœè¡ç 现èã§ããããã®ãããªè «
ãã现èãæ£åžžãªæ©èœããã€ã现èãžãšååãèª
å°ããã®ããååèªå°èœããã€ãç©è³ªã§ãããã
ããååèªå°èœããã€ãç©è³ªãçšããããšã«ã
ããæ°ããçã®æ²»çæ¹æ³ãéçºã§ãããã®ãšã
ãŠãè¿å¹Žã泚ç®ãããŠããã
ååèªå°èœããã€ãç©è³ªãšããŠã¯ãå®å
šæ§ã®é«
ãèçœæ§ã®ç©è³ªãç¹ã«ããç±æ¥ã®èçœæ§ã®ç©è³ªã
æåŸ ãéããè¿å¹ŽæŽ»çºã«ç 究ããªãããŠãããçŸ
åšãŸã§ã«ãããæ«æ¢¢è¡ãªã³ãçãã¬ã¯ãã³ã§åºæ¿
ããããšã«ãããååèªå°æŽ»æ§ãçæãããããš
ãå ±åãããŠããïŒãžã€ãŒãã« ãã·ãšãã« ã«
ã³ãµãŒ ã€ã³ã¹ãããŠãŒãïŒJ.National Cancer
lnstituteïŒ67å·»ã1225é ïŒ1981幎ïŒãã«ã³ãµãŒãª
ãµãŒãïŒCancer ResearchïŒ42å·»ã3928é ïŒ1982
幎ïŒïŒãããããªãããããã®å ±åã«ãããŠããã
æ«æ¢¢è¡ãªã³ãçããåŸããããã®ã¯ãã»ãã¢ãã
ã¯ã¹ïŒ§â75ïŒãã¢ã«ãã·ã¢ç€Ÿãã¹ãŠãšãŒãã³ïŒã
çšããã²ã«ãéåç»æ³ã«ãã€ãŠååé25000ãš
40000ã®èçœæ§ç©è³ªã§ããããšãå ±åãããŠãã
ã®ã¿ã§ãã€ããããã®åŸã®ç 究ã«ãããŠãå ¬éç¹
èš±å ¬å ±ãæ60â28934å·ã«ç€ºãããååé45000ã
60000ãŸãã¯100000ãçé»ç¹ïŒãïŒã®ç©è³ªã§ããã
ããªãã·ã³ã«æåæ§ã瀺ããç±ã«äžå®å®ãªç©è³ªã§
ãããšããããäžæ¹ãããââãªã³ãçæ§çœè¡
ç 现èã®å¹é€äžæž äžã«èŠãã ãããååèªå°æŽ»æ§
ã¯ãã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åæ³ã«ãã€ãŠãå
åé50000ã60000ã®èçœæ§ã®ç©è³ªã«ç±æ¥ãããã®
ãšãããããåé¢å·¥çšäžã§ããã®æŽ»æ§ã®çŽ60ã90
ïŒ ã倱ãããïŒæ¥æ¬çµç¹å¹é€åŠäŒèŠæšã43é ã
ïŒ1983幎ïŒïŒã
ãèçœæ§ã®ç©è³ªãç¹ã«ããç±æ¥ã®èçœæ§ã®ç©è³ªã
æåŸ ãéããè¿å¹ŽæŽ»çºã«ç 究ããªãããŠãããçŸ
åšãŸã§ã«ãããæ«æ¢¢è¡ãªã³ãçãã¬ã¯ãã³ã§åºæ¿
ããããšã«ãããååèªå°æŽ»æ§ãçæãããããš
ãå ±åãããŠããïŒãžã€ãŒãã« ãã·ãšãã« ã«
ã³ãµãŒ ã€ã³ã¹ãããŠãŒãïŒJ.National Cancer
lnstituteïŒ67å·»ã1225é ïŒ1981幎ïŒãã«ã³ãµãŒãª
ãµãŒãïŒCancer ResearchïŒ42å·»ã3928é ïŒ1982
幎ïŒïŒãããããªãããããã®å ±åã«ãããŠããã
æ«æ¢¢è¡ãªã³ãçããåŸããããã®ã¯ãã»ãã¢ãã
ã¯ã¹ïŒ§â75ïŒãã¢ã«ãã·ã¢ç€Ÿãã¹ãŠãšãŒãã³ïŒã
çšããã²ã«ãéåç»æ³ã«ãã€ãŠååé25000ãš
40000ã®èçœæ§ç©è³ªã§ããããšãå ±åãããŠãã
ã®ã¿ã§ãã€ããããã®åŸã®ç 究ã«ãããŠãå ¬éç¹
èš±å ¬å ±ãæ60â28934å·ã«ç€ºãããååé45000ã
60000ãŸãã¯100000ãçé»ç¹ïŒãïŒã®ç©è³ªã§ããã
ããªãã·ã³ã«æåæ§ã瀺ããç±ã«äžå®å®ãªç©è³ªã§
ãããšããããäžæ¹ãããââãªã³ãçæ§çœè¡
ç 现èã®å¹é€äžæž äžã«èŠãã ãããååèªå°æŽ»æ§
ã¯ãã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åæ³ã«ãã€ãŠãå
åé50000ã60000ã®èçœæ§ã®ç©è³ªã«ç±æ¥ãããã®
ãšãããããåé¢å·¥çšäžã§ããã®æŽ»æ§ã®çŽ60ã90
ïŒ ã倱ãããïŒæ¥æ¬çµç¹å¹é€åŠäŒèŠæšã43é ã
ïŒ1983幎ïŒïŒã
ãã®ããã«ãããæ«æ¢¢è¡ãªã³ãçããã³ããâ
âãªã³ãçæ§çœè¡ç 现èããçæãããååèª
å°æŽ»æ§ã¯ããã®æŽ»æ§ãããããç©è³ªã®æ§è³ªã¯ã»ãš
ãã©ããã€ãŠããªãããç±ãèçœè³ªåè§£é µçŽ ã«åŒ·
ãæåæ§ã瀺ãäžå®å®ãªç©è³ªã§ãããšå ±ã«ããã
ãã®ç©è³ªã®æŽ»æ§ã¯åŒ±ãããã¿ãã³ïŒ¡èªå°äœãªã©ã
å ±åããªããšãçœè¡ç 现èã«å åãªååãèªå°ã
ãããšãã§ããªãã€ãã
âãªã³ãçæ§çœè¡ç 现èããçæãããååèª
å°æŽ»æ§ã¯ããã®æŽ»æ§ãããããç©è³ªã®æ§è³ªã¯ã»ãš
ãã©ããã€ãŠããªãããç±ãèçœè³ªåè§£é µçŽ ã«åŒ·
ãæåæ§ã瀺ãäžå®å®ãªç©è³ªã§ãããšå ±ã«ããã
ãã®ç©è³ªã®æŽ»æ§ã¯åŒ±ãããã¿ãã³ïŒ¡èªå°äœãªã©ã
å ±åããªããšãçœè¡ç 现èã«å åãªååãèªå°ã
ãããšãã§ããªãã€ãã
ãŸããããæ«æ¢¢è¡ãªã³ãçã¯ããã®è¡æ¶²ããæ¡
åãããè¡çãåç»ããŠèª¿è£œãããããã倧éã«
ååŸããããšã¯å°é£ã§ãããå·¥æ¥ççç£ã¯å®¹æã§
ã¯ãªãã€ãããŸãããââãªã³ãæ§çœè¡ç 现è
ã¯ãããã®ïŒŽçŽ°èçœè¡ç ãŠã€ã«ã¹ã«ç¶æææãã
ããšã«ãã€ãŠãå¢æ®æ§ãç²åŸãããã®ã§ããã倧
éã®çŽ°èå¹é€ã¯å®å šæ§ã®ç¹ã§åé¡ãå€ãã€ãã
åãããè¡çãåç»ããŠèª¿è£œãããããã倧éã«
ååŸããããšã¯å°é£ã§ãããå·¥æ¥ççç£ã¯å®¹æã§
ã¯ãªãã€ãããŸãããââãªã³ãæ§çœè¡ç 现è
ã¯ãããã®ïŒŽçŽ°èçœè¡ç ãŠã€ã«ã¹ã«ç¶æææãã
ããšã«ãã€ãŠãå¢æ®æ§ãç²åŸãããã®ã§ããã倧
éã®çŽ°èå¹é€ã¯å®å šæ§ã®ç¹ã§åé¡ãå€ãã€ãã
æ¬çºæè
ãã¯ãäžèšå
è¡ç¥èŠãèªèãããã¯ã
ãã¢ãŒãžïŒÎÏïŒç³»ã®çŽ°èããããå®å®æ§ã«åªã
ãã匷ã现èååèªå°äœçšãæããèçœæ§ã®çç
掻æ§ç©è³ªãç£çãããšã®äœæ¥ä»®èª¬ã«åºããŠãéæ
æ€èšãç¶ããããã®ÎÏåé§çŽ°èã«äœçšããŠãå
ç¬ã§ãÎÏãžãšååãèªå°ããã掻æ§ãæããã
ãç±æ¥ã®èçœæ§ã®çŽ°èååèªå°ç©è³ªãèŠãã ãã
çºæãå®æããç¹èš±åºé¡ãè¡ãªã€ããããããªã
ããå é¡ã§ã¯ãÎÏåé§çŽ°èã§ããçœè¡ç 现èã
䜿çšããå Žåã«ãããŠããÎÏåé§çŽ°èãÎÏæ§
现èãžå€åãããåŸãååèªå°å€ãæŽæµãé€å»ã
ãããã«ã倧å€æéåãã倧éã®çŽ°èãåŠçãã
ããšããããããã€ããããã§ã现èååèªå°ç©
質ã倧éãã€å®¹æã«ååŸããããã®æ段ã«ã€ã
ãŠãæ€èšããããããåŸæ¥ããã¯ããã¢ãŒãžã¯åš
å£ãžã®åŒ·ãä»çæ§ã瀺ãããŸãä»çç¶æ ã«ãã
ãŠããã¯ããã¢ãŒãžã®ãã€çš®ã ã®æ©èœãçºæ®ãã
ããã®ãšèããããŠãããããããªãããæå€ã«
ãÎÏæ§çŽ°èã«ååãããããçœè¡ç 现èãçš
ããååèªå°èœãæããç©è³ªããã³ÎÏ掻æ§åç©
質ã®ååšäžã«æ¹ã¯ãå¹é€ããããšã«ãããé«æ¿åºŠ
ã§çŽ°èååèªå°ç©è³ªãç£çããããšãèŠãã ãæ¬
çºæãå®æããããã®ããã«ããããšã«ãããã¯
ãããŠå®å šã«å€§éã®çŽ°èãåãæ±ãããšãã§ãã
ãã€å®¹æã«å¹é€è£ 眮ã倧ååã§ããããã现èå
åèªå°ç©è³ªã倧éã«ååŸã§ããããã«ãªã€ãã®ã§
ããã
ãã¢ãŒãžïŒÎÏïŒç³»ã®çŽ°èããããå®å®æ§ã«åªã
ãã匷ã现èååèªå°äœçšãæããèçœæ§ã®çç
掻æ§ç©è³ªãç£çãããšã®äœæ¥ä»®èª¬ã«åºããŠãéæ
æ€èšãç¶ããããã®ÎÏåé§çŽ°èã«äœçšããŠãå
ç¬ã§ãÎÏãžãšååãèªå°ããã掻æ§ãæããã
ãç±æ¥ã®èçœæ§ã®çŽ°èååèªå°ç©è³ªãèŠãã ãã
çºæãå®æããç¹èš±åºé¡ãè¡ãªã€ããããããªã
ããå é¡ã§ã¯ãÎÏåé§çŽ°èã§ããçœè¡ç 现èã
䜿çšããå Žåã«ãããŠããÎÏåé§çŽ°èãÎÏæ§
现èãžå€åãããåŸãååèªå°å€ãæŽæµãé€å»ã
ãããã«ã倧å€æéåãã倧éã®çŽ°èãåŠçãã
ããšããããããã€ããããã§ã现èååèªå°ç©
質ã倧éãã€å®¹æã«ååŸããããã®æ段ã«ã€ã
ãŠãæ€èšããããããåŸæ¥ããã¯ããã¢ãŒãžã¯åš
å£ãžã®åŒ·ãä»çæ§ã瀺ãããŸãä»çç¶æ ã«ãã
ãŠããã¯ããã¢ãŒãžã®ãã€çš®ã ã®æ©èœãçºæ®ãã
ããã®ãšèããããŠãããããããªãããæå€ã«
ãÎÏæ§çŽ°èã«ååãããããçœè¡ç 现èãçš
ããååèªå°èœãæããç©è³ªããã³ÎÏ掻æ§åç©
質ã®ååšäžã«æ¹ã¯ãå¹é€ããããšã«ãããé«æ¿åºŠ
ã§çŽ°èååèªå°ç©è³ªãç£çããããšãèŠãã ãæ¬
çºæãå®æããããã®ããã«ããããšã«ãããã¯
ãããŠå®å šã«å€§éã®çŽ°èãåãæ±ãããšãã§ãã
ãã€å®¹æã«å¹é€è£ 眮ã倧ååã§ããããã现èå
åèªå°ç©è³ªã倧éã«ååŸã§ããããã«ãªã€ãã®ã§
ããã
ããªãã¡ãæ¬çºæã¯ãã¯ããã¢ãŒãžæ§çŽ°èã«å
åãããããçœè¡ç 现èããååèªå°èœãæãã
ç©è³ªããã³ãã¯ããã¢ãŒãžæŽ»æ§åç©è³ªã®ååšäžã«
æ¹æå¹é€ããããšãç¹åŸŽãšããçœè¡ç 现èã«å¯Ÿã
ãŠçŽ°èååèªå°æŽ»æ§ãæããããç±æ¥çç掻æ§ç©
質ã®çç£æ¹æ³ã«é¢ããçç£ãããçç掻æ§ç©è³ªã¯
äžèšã®ç¹æ§ãæãããïœ ååé 50000±5000
ïŒã²ã«æ¿Ÿéæ³ïŒ 50000±5000ïŒSDSâããªã¢ã¯ãªã«ã¢ããé»æ°
æ³³åæ³ïŒ ïœ ã¬ã¯ãã³ã«ã©ã ãžã®åžçæ§ ã¬ã³ãã«ã¬ã¯ã
ã³ã«ã©ã ãã³ã³ã«ãããªã³ïŒ¡ã«ã©ã ã«åžçãã ïœ ç±å®å®æ§ 70âïŒæéã§å€±æŽ»ããªã ïœ éå å€ã«ããåœ±é¿ æŽ»æ§ãäœäžãã ïœ PHå®å®æ§ PHïŒã10ã®ç¯å²ã§å®å®ã§ãã æ¬çºæã«ãããŠã现èååèªå°ç©è³ªãšã¯ããç±
æ¥ã®ÎÏæ§çŽ°èãç£çããç©è³ªã§ãã€ãŠin vitro
ã§å°ãªããšãããŠã¹ÎâïŒçŽ°èãååãããã©ã
è²èœãèªèµ·ããèœåãæãããã®ãæå³ããã
åãããããçœè¡ç 现èããååèªå°èœãæãã
ç©è³ªããã³ãã¯ããã¢ãŒãžæŽ»æ§åç©è³ªã®ååšäžã«
æ¹æå¹é€ããããšãç¹åŸŽãšããçœè¡ç 现èã«å¯Ÿã
ãŠçŽ°èååèªå°æŽ»æ§ãæããããç±æ¥çç掻æ§ç©
質ã®çç£æ¹æ³ã«é¢ããçç£ãããçç掻æ§ç©è³ªã¯
äžèšã®ç¹æ§ãæãããïœ ååé 50000±5000
ïŒã²ã«æ¿Ÿéæ³ïŒ 50000±5000ïŒSDSâããªã¢ã¯ãªã«ã¢ããé»æ°
æ³³åæ³ïŒ ïœ ã¬ã¯ãã³ã«ã©ã ãžã®åžçæ§ ã¬ã³ãã«ã¬ã¯ã
ã³ã«ã©ã ãã³ã³ã«ãããªã³ïŒ¡ã«ã©ã ã«åžçãã ïœ ç±å®å®æ§ 70âïŒæéã§å€±æŽ»ããªã ïœ éå å€ã«ããåœ±é¿ æŽ»æ§ãäœäžãã ïœ PHå®å®æ§ PHïŒã10ã®ç¯å²ã§å®å®ã§ãã æ¬çºæã«ãããŠã现èååèªå°ç©è³ªãšã¯ããç±
æ¥ã®ÎÏæ§çŽ°èãç£çããç©è³ªã§ãã€ãŠin vitro
ã§å°ãªããšãããŠã¹ÎâïŒçŽ°èãååãããã©ã
è²èœãèªèµ·ããèœåãæãããã®ãæå³ããã
æ¬çºæã®æ¹æ³ã«ããã°ãå¹é€èŠæš¡ã調ç¯ããã
ãšã«ããä»»æã®éã®çŽ°èååèªå°ç©è³ªããéæã
補é ããããšãã§ããã
ãšã«ããä»»æã®éã®çŽ°èååèªå°ç©è³ªããéæã
補é ããããšãã§ããã
æ¬çºæã§çšããããÎÏæ§çŽ°èã«ååãããã
ãçœè¡ç 现èãšã¯ãÎÏåé§çŽ°èã«çžåœããåå
èªå°èœãæããç©è³ªïŒä»¥äžãååèªå°èœå€ãšç¥
ãïŒã®äœçšã«ããå§ããŠÎÏæ§çŽ°èã«å€åãã现
èåã¯æ¬æ¥ÎÏã®æ§è³ªã®äžéšãæããŠããããå
åèªå°å€ã®äœçšã«ããæŽã«ÎÏã®æ§è³ªãæããã
ãã«å€åãã现èãæå³ãããÎÏåé§çŽ°èã¯ã
çœè¡ç æ£è ããåé¢ããå代现èåã³æ ªå现èãª
ã©ããåŸãããããæ ªå现èã倧éã«åŸããã奜
ãŸãããæ¬çºæã§çšããããçœè¡ç 现èã®æ ªå现
èã®äŸãšããŠã¯ãHLâ60现èïŒãã€ãã€ãŒ
ïŒNatureïŒã270å·»ã347é ïŒ1977幎ïŒïŒãTHPâïŒ
现èïŒã€ã³ã¿ãŒãã·ãšãã« ãžã€ãŒãã« ã«ã³ãµ
ãŒïŒInt.J.CancerïŒ26å·»ã171é ïŒ1980幎ïŒïŒã
MonoâïŒâ207现èïŒãŠã€ã«ããšãŒãº ã¢ã«ã
ãŒã ã¢ãŒ ããœããžã«ã« ã¢ããã㌠ãã¹ã
ããœããžãŒïŒVirchows Arch.A Path.Anat.and
Histol.371å·»ã15é ïŒ1976幎ïŒïŒãªã©ãæããã
ããããã§çšããããååèªå°å€ãšããŠã¯ãÎÏ
æ§çŽ°èãžå€åãåŸãçœè¡ç 现èã®ÎÏæ§çŽ°èãžã®
å€åãèªå°ããç©è³ªãæå³ããäŸãã°ããã«ããŒ
ã«ãšã¹ãã«é¡ãã¡ãŒã¬ã€ã³ã®ãããªãžãã«ãã³ç³»
ååç©ããã¬ãªã·ãžã³ãªã©ãæããããããã«ã
ãŒã«ãšã¹ãã«é¡ã§ã¯ã4βâããããã·äœã奜ãŸ
ãããäžã§ã12âïŒâããã©ãã«ãã€ã«ãã«ããŒ
ã«â13âã¢ã»ããŒãïŒä»¥äžãTPAãšç¥èšããïŒ
ãç¹ã«å¥œãŸããã
ãçœè¡ç 现èãšã¯ãÎÏåé§çŽ°èã«çžåœããåå
èªå°èœãæããç©è³ªïŒä»¥äžãååèªå°èœå€ãšç¥
ãïŒã®äœçšã«ããå§ããŠÎÏæ§çŽ°èã«å€åãã现
èåã¯æ¬æ¥ÎÏã®æ§è³ªã®äžéšãæããŠããããå
åèªå°å€ã®äœçšã«ããæŽã«ÎÏã®æ§è³ªãæããã
ãã«å€åãã现èãæå³ãããÎÏåé§çŽ°èã¯ã
çœè¡ç æ£è ããåé¢ããå代现èåã³æ ªå现èãª
ã©ããåŸãããããæ ªå现èã倧éã«åŸããã奜
ãŸãããæ¬çºæã§çšããããçœè¡ç 现èã®æ ªå现
èã®äŸãšããŠã¯ãHLâ60现èïŒãã€ãã€ãŒ
ïŒNatureïŒã270å·»ã347é ïŒ1977幎ïŒïŒãTHPâïŒ
现èïŒã€ã³ã¿ãŒãã·ãšãã« ãžã€ãŒãã« ã«ã³ãµ
ãŒïŒInt.J.CancerïŒ26å·»ã171é ïŒ1980幎ïŒïŒã
MonoâïŒâ207现èïŒãŠã€ã«ããšãŒãº ã¢ã«ã
ãŒã ã¢ãŒ ããœããžã«ã« ã¢ããã㌠ãã¹ã
ããœããžãŒïŒVirchows Arch.A Path.Anat.and
Histol.371å·»ã15é ïŒ1976幎ïŒïŒãªã©ãæããã
ããããã§çšããããååèªå°å€ãšããŠã¯ãÎÏ
æ§çŽ°èãžå€åãåŸãçœè¡ç 现èã®ÎÏæ§çŽ°èãžã®
å€åãèªå°ããç©è³ªãæå³ããäŸãã°ããã«ããŒ
ã«ãšã¹ãã«é¡ãã¡ãŒã¬ã€ã³ã®ãããªãžãã«ãã³ç³»
ååç©ããã¬ãªã·ãžã³ãªã©ãæããããããã«ã
ãŒã«ãšã¹ãã«é¡ã§ã¯ã4βâããããã·äœã奜ãŸ
ãããäžã§ã12âïŒâããã©ãã«ãã€ã«ãã«ããŒ
ã«â13âã¢ã»ããŒãïŒä»¥äžãTPAãšç¥èšããïŒ
ãç¹ã«å¥œãŸããã
æ¬çºæã«ãããŠçšããããÎÏ掻æ§åç©è³ªãšã
ãŠã¯ããã¿ãã³ïŒ¡èªå°äœïŒäŸãã°ããã¿ãã³ïŒ¡
é žããã¿ãã³ïŒ¡ã¢ã«ã³ãŒã«ããã¿ãã³ïŒ¡ã¢ã»ããŒ
ãããã¿ãã³ïŒ¡ãã«ãããŒãïŒããžã¡ãã«ã¹ã«ã
ãã·ããé ªé žãããªãŠã å¡©ããã€ããã³ãŒããŸ
ã³ãã°ã©ã é°æ§èç±æ¥ã®ãªãããªãµãã«ã©ã€ã
ïŒä»¥äžLPSãšç¥ãïŒããªããããBCGèãªã©ã®
èäœå£ãã ã©ãã«ãžãããããªã©ãæããããã
ãããåç¬ããããã¯é©å®çµã¿åãããŠçšããã
ãšã«ãããÎÏã掻æ§åããã现èååèªå°ç©è³ª
ã®ç£çãä¿ãããšãã§ããããããÎÏ掻æ§åç©
質ã®äžã§ããçŽïŒã5000ngïŒmlã奜ãŸããã¯çŽ
100ã3000ngïŒmlããã奜ãŸããã¯çŽ500ã
2000ngïŒmlã®ãã¿ãã³ïŒ¡èªå°äœãäžã§ããã¿ã
ã³ïŒ¡é žã®äœ¿çšãç¹ã«å¥œãŸããã
ãŠã¯ããã¿ãã³ïŒ¡èªå°äœïŒäŸãã°ããã¿ãã³ïŒ¡
é žããã¿ãã³ïŒ¡ã¢ã«ã³ãŒã«ããã¿ãã³ïŒ¡ã¢ã»ããŒ
ãããã¿ãã³ïŒ¡ãã«ãããŒãïŒããžã¡ãã«ã¹ã«ã
ãã·ããé ªé žãããªãŠã å¡©ããã€ããã³ãŒããŸ
ã³ãã°ã©ã é°æ§èç±æ¥ã®ãªãããªãµãã«ã©ã€ã
ïŒä»¥äžLPSãšç¥ãïŒããªããããBCGèãªã©ã®
èäœå£ãã ã©ãã«ãžãããããªã©ãæããããã
ãããåç¬ããããã¯é©å®çµã¿åãããŠçšããã
ãšã«ãããÎÏã掻æ§åããã现èååèªå°ç©è³ª
ã®ç£çãä¿ãããšãã§ããããããÎÏ掻æ§åç©
質ã®äžã§ããçŽïŒã5000ngïŒmlã奜ãŸããã¯çŽ
100ã3000ngïŒmlããã奜ãŸããã¯çŽ500ã
2000ngïŒmlã®ãã¿ãã³ïŒ¡èªå°äœãäžã§ããã¿ã
ã³ïŒ¡é žã®äœ¿çšãç¹ã«å¥œãŸããã
现èååèªå°ç©è³ªç£çã«å
åãªæéãããç±æ¥
ã®çœè¡ç 现èãå¹é€ããåŸãå¹é€äžæž ãåéãã
é å¿åé¢ã«ãã现èå±ãé€å»ããã°ã现èååèª
å°ç©è³ªãå«ã溶液ãåŸãããããã®çŽ°èååèªå°
ç©è³ªãå«ã溶液ãçååŠçåé¢æäœã«ãããåžž
æ³ãéå€ãéã«ããæ¿çž®ãéæè±å¡©ãé°ã€ãªã³äº€
æäœã«ããã€ãªã³äº€æã¯ãããã°ã©ãã€ãŒãã²ã«
ãéãé»æ°æ³³åçãé©å®çµã¿åãããŠç²Ÿè£œããã
ãšã«ãããé«çŽåºŠã®çŽ°èååèªå°ç©è³ªãåŸãããš
ãã§ããã
ã®çœè¡ç 现èãå¹é€ããåŸãå¹é€äžæž ãåéãã
é å¿åé¢ã«ãã现èå±ãé€å»ããã°ã现èååèª
å°ç©è³ªãå«ã溶液ãåŸãããããã®çŽ°èååèªå°
ç©è³ªãå«ã溶液ãçååŠçåé¢æäœã«ãããåžž
æ³ãéå€ãéã«ããæ¿çž®ãéæè±å¡©ãé°ã€ãªã³äº€
æäœã«ããã€ãªã³äº€æã¯ãããã°ã©ãã€ãŒãã²ã«
ãéãé»æ°æ³³åçãé©å®çµã¿åãããŠç²Ÿè£œããã
ãšã«ãããé«çŽåºŠã®çŽ°èååèªå°ç©è³ªãåŸãããš
ãã§ããã
现èååèªå°ç©è³ªã®æŽ»æ§ã®æž¬å®ã¯ãin vitroã§
ããŠã¹éªšé«æ§çœè¡ç 现èÎâïŒçŽ°èã«ãã©ãé£èœ
ãèªèµ·ããå¹æã枬å®ããããšã«ããè¡ãªã€ãã
æ¬çºæè ããçšããŠããæ¹æ³ã¯ãæã®æ¹æ³ïŒãã
ã·ã³ããžãŒããªãŒã©ã ãïŒå·»ã50é ïŒ1984幎ïŒïŒ
ãæ¹è¯ãããã®ã§ãããå³ã¡ãå¢æ®æã«ããÎâ
ïŒçŽ°èïŒÃ105cellsïŒmlïŒå¹å°ïŒã€ãŒã°ã«MEM
ïŒïŒå¹éãã¿ãã³ã»ã¢ããé žïŒ10ïŒ çèæ²»è¡æž ïŒ
æµ®é液ã«çŽ°èååèªå°ç©è³ªæº¶æ¶²ïŒè©Šéšæ¶²ïŒãæ··
ãããã®ïŒmlã10mlã¬ã©ã¹ç®¡ã«ãšãã暪ã«åã
ãŠãçé žã¬ã¹å¹é€åšäžã§ã37âã§ïŒæ¥éå¹é€åŸã
é å¿åŠçïŒ1000rpm.10åéïŒãæœããäžæŸã¿æ¶²
ãæšãŠãè¡æž ãå«ãŸãªãå¹é€æ¶²ïŒmlãå ããŠåã³
现èãæžæ¿ãã2ÎŒlïŒmlã®æ¿åºŠã®ããªã¹ãã¬ã³ã»
ã©ããã¯ã¹ç²åïŒ1.004ÎŒïœïŒç©æ°ŽååŠç€Ÿè£œïŒãå
ãæ¹ã¯ãããåŸãããã«ïŒæéå¹é€ããããã®çŽ°
èãPBS1mlã§ããæŽæµãé å¿ãã现èå€ã®ã©ã
ãã¯ã¹ç²åãé€å»ããããã®æäœãïŒåç¹°ãè¿ã
ãã®ã¡ãé å¿ç®¡ã®åºã«æ²æŸ±ãã现èãããããã§
åžãäžããã¹ã©ã€ãã¬ã©ã¹äžã«ïŒæ»Žèœãšãããã
ã«0.5ïŒ ãšãªã·ã³æ¶²ïŒæ»Žãå ããã«ããŒã¬ã©ã¹ã
ã®ããé¡åŸ®é¡ã§èŠ³å¯ãããèµ€ãæè²ãããæ»çŽ°è
ãé€ããç现èã®ã¿ã«ã€ããŠãã©ããã¯ã¹ç²åã
ã©ãé£ãã现èãšéã©ãé£çŽ°èãšãèšæ°ããã©ã
é£çŽ°èã®æ¯çãæ±ãããè©Šéšæ¶²ãé©å®åžéããŠã
äžèšã®æž¬å®ãè¡ãªããã©ãé£çŽ°èã®æ¯çã10ïŒ ã«
ãªãã®ã«å¿ èŠãªã现èååèªå°ç©è³ªã®è©Šæã®åžé
çã®éæ°ããã€ãŠãæ¬çºæã«ããã现èååèªå°
ç©è³ªã®æŽ»æ§éãïŒåäœïŒïŒµïŒïŒmlãšå®çŸ©ããã以
äžæ¬çºæã«ããã现èååèªå°ç©è³ªã®æŽ»æ§éã¯ã
ãã®ã©ãé£èœæž¬å®æ³ã«ãã€ãŠæž¬å®ããåäœã§ç€ºã
ããŠããã
ããŠã¹éªšé«æ§çœè¡ç 现èÎâïŒçŽ°èã«ãã©ãé£èœ
ãèªèµ·ããå¹æã枬å®ããããšã«ããè¡ãªã€ãã
æ¬çºæè ããçšããŠããæ¹æ³ã¯ãæã®æ¹æ³ïŒãã
ã·ã³ããžãŒããªãŒã©ã ãïŒå·»ã50é ïŒ1984幎ïŒïŒ
ãæ¹è¯ãããã®ã§ãããå³ã¡ãå¢æ®æã«ããÎâ
ïŒçŽ°èïŒÃ105cellsïŒmlïŒå¹å°ïŒã€ãŒã°ã«MEM
ïŒïŒå¹éãã¿ãã³ã»ã¢ããé žïŒ10ïŒ çèæ²»è¡æž ïŒ
æµ®é液ã«çŽ°èååèªå°ç©è³ªæº¶æ¶²ïŒè©Šéšæ¶²ïŒãæ··
ãããã®ïŒmlã10mlã¬ã©ã¹ç®¡ã«ãšãã暪ã«åã
ãŠãçé žã¬ã¹å¹é€åšäžã§ã37âã§ïŒæ¥éå¹é€åŸã
é å¿åŠçïŒ1000rpm.10åéïŒãæœããäžæŸã¿æ¶²
ãæšãŠãè¡æž ãå«ãŸãªãå¹é€æ¶²ïŒmlãå ããŠåã³
现èãæžæ¿ãã2ÎŒlïŒmlã®æ¿åºŠã®ããªã¹ãã¬ã³ã»
ã©ããã¯ã¹ç²åïŒ1.004ÎŒïœïŒç©æ°ŽååŠç€Ÿè£œïŒãå
ãæ¹ã¯ãããåŸãããã«ïŒæéå¹é€ããããã®çŽ°
èãPBS1mlã§ããæŽæµãé å¿ãã现èå€ã®ã©ã
ãã¯ã¹ç²åãé€å»ããããã®æäœãïŒåç¹°ãè¿ã
ãã®ã¡ãé å¿ç®¡ã®åºã«æ²æŸ±ãã现èãããããã§
åžãäžããã¹ã©ã€ãã¬ã©ã¹äžã«ïŒæ»Žèœãšãããã
ã«0.5ïŒ ãšãªã·ã³æ¶²ïŒæ»Žãå ããã«ããŒã¬ã©ã¹ã
ã®ããé¡åŸ®é¡ã§èŠ³å¯ãããèµ€ãæè²ãããæ»çŽ°è
ãé€ããç现èã®ã¿ã«ã€ããŠãã©ããã¯ã¹ç²åã
ã©ãé£ãã现èãšéã©ãé£çŽ°èãšãèšæ°ããã©ã
é£çŽ°èã®æ¯çãæ±ãããè©Šéšæ¶²ãé©å®åžéããŠã
äžèšã®æž¬å®ãè¡ãªããã©ãé£çŽ°èã®æ¯çã10ïŒ ã«
ãªãã®ã«å¿ èŠãªã现èååèªå°ç©è³ªã®è©Šæã®åžé
çã®éæ°ããã€ãŠãæ¬çºæã«ããã现èååèªå°
ç©è³ªã®æŽ»æ§éãïŒåäœïŒïŒµïŒïŒmlãšå®çŸ©ããã以
äžæ¬çºæã«ããã现èååèªå°ç©è³ªã®æŽ»æ§éã¯ã
ãã®ã©ãé£èœæž¬å®æ³ã«ãã€ãŠæž¬å®ããåäœã§ç€ºã
ããŠããã
äžèšã®çŽ°èã®å¹é€ã«ããç£çããããæ¬çºæã®
现èååèªå°ç©è³ªã®æ§è³ªã詳ããè¿°ã¹ãã
现èååèªå°ç©è³ªã®æ§è³ªã詳ããè¿°ã¹ãã
 ååéïŒ50000±5000ïŒã²ã«ãéæ³ïŒ
ãã«ããã³ãªã³é
žç·©è¡æ¶²ïŒå¡©åã«ãªãŠã 0.2gïŒ
ïœãå¡©åãããªãŠã 8gïŒïœããªã³é žç¬¬ïŒã«ãªãŠ
ã 0.2gïŒïœããªã³é žç¬¬ïŒãããªãŠã 1.15gïŒïœã
pH7.4ïŒã«0.01ïŒ ããªãšãã¬ã³ã°ãªã³ãŒã«ãæ·»å
ãã溶液ã«ãŠå¹³è¡¡åããSuperose6ïŒSuperose12
ïŒãã¢ã«ãã·ã¢ç€ŸïŒã¹ãŠãšãŒãã³ïŒè£œïŒãçšãã
ã²ã«ãéæ³ã«ããåç»ããÎâïŒçŽ°èã§ã®ã©ãé£
èœã®èªèµ·ã«ãã现èååèªå°æŽ»æ§åã枬å®ããã
ïœãå¡©åãããªãŠã 8gïŒïœããªã³é žç¬¬ïŒã«ãªãŠ
ã 0.2gïŒïœããªã³é žç¬¬ïŒãããªãŠã 1.15gïŒïœã
pH7.4ïŒã«0.01ïŒ ããªãšãã¬ã³ã°ãªã³ãŒã«ãæ·»å
ãã溶液ã«ãŠå¹³è¡¡åããSuperose6ïŒSuperose12
ïŒãã¢ã«ãã·ã¢ç€ŸïŒã¹ãŠãšãŒãã³ïŒè£œïŒãçšãã
ã²ã«ãéæ³ã«ããåç»ããÎâïŒçŽ°èã§ã®ã©ãé£
èœã®èªèµ·ã«ãã现èååèªå°æŽ»æ§åã枬å®ããã
 ååéïŒ50000±5000ïŒSDSâããªã¢ã¯ãªã«ã¢
ããé»æ°æ³³åæ³ïŒ Segrestãã®æ¹æ³ãã¡ãœãã ã€ã³ ãšã³ã¶ã€
ã¢ããžãŒïŒMethod in EnzymologyïŒ28â巻ã
54é ïŒ1972幎ïŒãã«åŸããããªã¹ïŒã°ãªã·ã³ïŒ
SDSïŒPH8.3ïŒã§ãé»æ°æ³³åãè¡ãªã€ããæšæºåå
éãããïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããŠååéæ€
éç·ãäœæããåç»ããã²ã«ããã®æœåºç©ã®Îâ
ïŒçŽ°èã®ã©ãé£èœèªèµ·æŽ»æ§è©äŸ¡ã«ããååéã決
å®ããã
ããé»æ°æ³³åæ³ïŒ Segrestãã®æ¹æ³ãã¡ãœãã ã€ã³ ãšã³ã¶ã€
ã¢ããžãŒïŒMethod in EnzymologyïŒ28â巻ã
54é ïŒ1972幎ïŒãã«åŸããããªã¹ïŒã°ãªã·ã³ïŒ
SDSïŒPH8.3ïŒã§ãé»æ°æ³³åãè¡ãªã€ããæšæºåå
éãããïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããŠååéæ€
éç·ãäœæããåç»ããã²ã«ããã®æœåºç©ã®Îâ
ïŒçŽ°èã®ã©ãé£èœèªèµ·æŽ»æ§è©äŸ¡ã«ããååéã決
å®ããã
以äžã®çµæãããæ¬çºæã®çŽ°èååèªå°ç©è³ªã¯
ãµãã»ãŠãããæ§é ãããšã€ãŠããªãç©è³ªã§ãã
ããšãåããã
ãµãã»ãŠãããæ§é ãããšã€ãŠããªãç©è³ªã§ãã
ããšãåããã
 çé»ç¹ïŒ6.5±1.0ïŒçé»ç¹é»æ°æ³³åæ³ïŒ
ã¢ããŒæ ªåŒäŒç€Ÿè£œã®çé»ç¹é»æ°æ³³åè£
眮
ïŒSJ1071ECåïŒãçšãããã¢ã«ãã©ã€ãïŒãã¢ã«
ãã·ã¢ç€Ÿè£œïŒãPHïŒãïŒïŒãšã°ãªã»ããŒã«ãå«ã
ïŒïŒ ããªã¢ã¯ãªã«ã¢ããå¹³æ¿ã²ã«ãäœæãããéœ
極åŽã«0.04M DLâã²ã«ã¿ãã³é žãé°æ¥µåŽã«0.2M
ãã¹ããžã³ã䜿çšããŠã700Vã§50åéã®åæ³³
åãè¡ãªããç¶ããŠè©Šæãä»äžãã700Vã§ïŒæ
éã500Vã§16æéæ³³åãè¡ãªããæ³³åçµäºåŸã²
ã«ã2.5mmå·Ÿã§åãåºãã次ãã§åã²ã«çã
0.15Må¡©åãããªãŠã ãå«ã0.02Mããªã¹âå¡©é ž
ç·©è¡æ¶²ïŒPH8.2ïŒ0.2mlã§æœåºããåæœåºæ¶²ã«ã€ã
ãŠãÎâïŒçŽ°èãçšãã现èååèªå°æŽ»æ§ã®è©äŸ¡
ãè¡ãªãã
ïŒSJ1071ECåïŒãçšãããã¢ã«ãã©ã€ãïŒãã¢ã«
ãã·ã¢ç€Ÿè£œïŒãPHïŒãïŒïŒãšã°ãªã»ããŒã«ãå«ã
ïŒïŒ ããªã¢ã¯ãªã«ã¢ããå¹³æ¿ã²ã«ãäœæãããéœ
極åŽã«0.04M DLâã²ã«ã¿ãã³é žãé°æ¥µåŽã«0.2M
ãã¹ããžã³ã䜿çšããŠã700Vã§50åéã®åæ³³
åãè¡ãªããç¶ããŠè©Šæãä»äžãã700Vã§ïŒæ
éã500Vã§16æéæ³³åãè¡ãªããæ³³åçµäºåŸã²
ã«ã2.5mmå·Ÿã§åãåºãã次ãã§åã²ã«çã
0.15Må¡©åãããªãŠã ãå«ã0.02Mããªã¹âå¡©é ž
ç·©è¡æ¶²ïŒPH8.2ïŒ0.2mlã§æœåºããåæœåºæ¶²ã«ã€ã
ãŠãÎâïŒçŽ°èãçšãã现èååèªå°æŽ»æ§ã®è©äŸ¡
ãè¡ãªãã
 ç±å®å®æ§
æ¬çºæã®çŽ°èååèªå°ç©è³ªã0.01ïŒ
ããªãšãã¬
ã³ã°ãªã³ãŒã«ãæ·»å ããPH7.4ãªã³é žç·©è¡æ¶²ã«ãŠ
ïŒåã«åžéããæå®ã®æéãæå®ã®æž©åºŠã«ãŠå ç±
ããåŸãÎâïŒçŽ°èãçšãã现èååèªå°æŽ»æ§ã®
è©äŸ¡ãè¡ãªããæ¬çºæã®çŽ°èååèªå°ç©è³ªã¯ã70
âãïŒæéã®ç±åŠçã«ãããŠããã®æŽ»æ§ã倱ããª
ããç±çã«å®å®ãªçç掻æ§ç©è³ªã§ããã
ã³ã°ãªã³ãŒã«ãæ·»å ããPH7.4ãªã³é žç·©è¡æ¶²ã«ãŠ
ïŒåã«åžéããæå®ã®æéãæå®ã®æž©åºŠã«ãŠå ç±
ããåŸãÎâïŒçŽ°èãçšãã现èååèªå°æŽ»æ§ã®
è©äŸ¡ãè¡ãªããæ¬çºæã®çŽ°èååèªå°ç©è³ªã¯ã70
âãïŒæéã®ç±åŠçã«ãããŠããã®æŽ»æ§ã倱ããª
ããç±çã«å®å®ãªçç掻æ§ç©è³ªã§ããã
 ã¬ã¯ãã³ã«ã©ã ãžã®åžçæ§
åžè²©ã®åçš®ã¬ã¯ãã³åºå®åæš¹èãåžè²©ã»ãã³ãŒ
ã«ããã«ã©ã ïŒãã€ãªã©ãã瀟補ïŒã«å å¡«ã
150mMã®å¡©åãããªãŠã ãå«ã50mMãªã³é žç·©
è¡æ¶²ïŒPH7.5ïŒã§å åã«æŽæµåŸãæ¬çºæã®çŽ°èå
åèªå°ç©è³ªè©Šæãæ·»å ããåç·©è¡æ¶²ã«ãŠæŽæµãã
次ãã§ãåçš®ç³é¡ãå«ã溶é¢æ¶²ã§æº¶åºãè¡ãªãã
ã³ã³ã«ãããªã³âãããã³ãã¬ã³ãã«ã¬ã¯ãã³
ã®ã«ã©ã ãçšããå Žåã«ãã¬ã¯ãã³ã«ã©ã ãžã®åž
çãèªãããããããã®ã«ã©ã ã«ãããŠã0.2Mα
âã¡ãã«âïœâãã³ãã·ã溶液ã«ããã现èåå
èªå°æŽ»æ§ã溶åºããã
ã«ããã«ã©ã ïŒãã€ãªã©ãã瀟補ïŒã«å å¡«ã
150mMã®å¡©åãããªãŠã ãå«ã50mMãªã³é žç·©
è¡æ¶²ïŒPH7.5ïŒã§å åã«æŽæµåŸãæ¬çºæã®çŽ°èå
åèªå°ç©è³ªè©Šæãæ·»å ããåç·©è¡æ¶²ã«ãŠæŽæµãã
次ãã§ãåçš®ç³é¡ãå«ã溶é¢æ¶²ã§æº¶åºãè¡ãªãã
ã³ã³ã«ãããªã³âãããã³ãã¬ã³ãã«ã¬ã¯ãã³
ã®ã«ã©ã ãçšããå Žåã«ãã¬ã¯ãã³ã«ã©ã ãžã®åž
çãèªãããããããã®ã«ã©ã ã«ãããŠã0.2Mα
âã¡ãã«âïœâãã³ãã·ã溶液ã«ããã现èåå
èªå°æŽ»æ§ã溶åºããã
 ãžã¹ã«ãã€ãçµåã®éå
å€ã«ãã圱é¿
ãžã¹ã«ãã€ãçµåã®éå
å€ãšããŠãžããªã¹ã¬ã€
ããŒã«ïŒDTTïŒãåã¯ãïŒâã¡ã«ã«ãããšã¿ããŒ
ã«ïŒïŒâMEïŒããæ¬çºæã«ãªã现èååèªå°ç©
質ã®æº¶æ¶²äžã«å ãã37âã§ãïŒæéåå¿ãããã
åå¿åŸãÎâïŒçŽ°èã«å¯Ÿããã©ãé£èœèªèµ·æŽ»æ§ã
枬å®ããã50mMã®ãžããªã¹ã¬ã€ããŒã«ãæ·»å ã
ãå Žåã«ããã®æŽ»æ§ã®äœäžãèªããããã
ããŒã«ïŒDTTïŒãåã¯ãïŒâã¡ã«ã«ãããšã¿ããŒ
ã«ïŒïŒâMEïŒããæ¬çºæã«ãªã现èååèªå°ç©
質ã®æº¶æ¶²äžã«å ãã37âã§ãïŒæéåå¿ãããã
åå¿åŸãÎâïŒçŽ°èã«å¯Ÿããã©ãé£èœèªèµ·æŽ»æ§ã
枬å®ããã50mMã®ãžããªã¹ã¬ã€ããŒã«ãæ·»å ã
ãå Žåã«ããã®æŽ»æ§ã®äœäžãèªããããã
 PHå®å®æ§
æ¬çºæã«ãªã现èååèªå°ç©è³ªãå«ã溶液ã«ã
ïŒåéã®åçš®PHã®ç·©è¡æ¶²ãæ·»å ãã24æéã37â
ã«å æž©ããåŸãPHãäžæ§ã«ãã©ããÎâïŒçŽ°èã«
察ãã现èååèªå°æŽ»æ§ã枬å®ãããPHïŒã10ã®
ç¯å²ã«ãããŠã掻æ§ã®äœäžã¯èªããããªãã
ïŒåéã®åçš®PHã®ç·©è¡æ¶²ãæ·»å ãã24æéã37â
ã«å æž©ããåŸãPHãäžæ§ã«ãã©ããÎâïŒçŽ°èã«
察ãã现èååèªå°æŽ»æ§ã枬å®ãããPHïŒã10ã®
ç¯å²ã«ãããŠã掻æ§ã®äœäžã¯èªããããªãã
 èçœå解é
µçŽ å®å®æ§
æ¬çºæã«ãªã现èååèªå°ç©è³ªãå«ã溶液ïŒPH
7.4ïŒã«èçœåè§£é µçŽ ããªãã·ã³ããŸãã¯ããã
ããŒãŒâïŒ200åäœïŒãæ·»å ãã37âã«ãŠãïŒæ
éåå¿ããããåå¿åŸã«ãããŠãÎâïŒçŽ°èã«å¯Ÿ
ãã现èååèªå°æŽ»æ§ã®äœäžã¯èªããããªããäž
èšå®éšã«0.1ïŒ SDSãæ·»å ããããšä»¥å€ã¯ãåäž
ã®æ¡ä»¶ã«ãŠèçœåè§£é µçŽ ã®å¹æãæ€èšãããšã
ãã0.1ïŒ SDSã®æ·»å æã®ããããŒãŒâã«ããã
现èååèªå°æŽ»æ§ãæ¶å€±ããããšãèªããããã
7.4ïŒã«èçœåè§£é µçŽ ããªãã·ã³ããŸãã¯ããã
ããŒãŒâïŒ200åäœïŒãæ·»å ãã37âã«ãŠãïŒæ
éåå¿ããããåå¿åŸã«ãããŠãÎâïŒçŽ°èã«å¯Ÿ
ãã现èååèªå°æŽ»æ§ã®äœäžã¯èªããããªããäž
èšå®éšã«0.1ïŒ SDSãæ·»å ããããšä»¥å€ã¯ãåäž
ã®æ¡ä»¶ã«ãŠèçœåè§£é µçŽ ã®å¹æãæ€èšãããšã
ãã0.1ïŒ SDSã®æ·»å æã®ããããŒãŒâã«ããã
现èååèªå°æŽ»æ§ãæ¶å€±ããããšãèªããããã
 ããçœè¡ç
现èã«å¯Ÿããççäœçš
çèå
è¡æž
ã10ïŒ
å«ãRPMIâ1640å¹å°ã«ãã
åçæ§çœè¡ç 现èïŒTHPâïŒïŒãããå骚é«æ§çœ
è¡ç 现èïŒHLâ60ïŒã37âãçé žã¬ã¹å¹é€åšäž
ã§ããããå¹é€ããå¢æ®æã«ãã现èããªã³é žç·©
è¡æ¶²ã§ããæŽæµããåŸãïŒïŒ çèå è¡æž ããã³
10nMãã¿ãã³ïŒ¡é žãæ·»å ããRPMIâ1640å¹å°
ïŒãã¿ãã³ãã¢ããé žåŒ·åïŒã«ãããããïŒÃ105
åïŒmlå¹å°ã«ãªãããã«æžæ¿ããã现èæžæ¿æ¶²
100ÎŒlãšçŽ°èååèªå°ç©è³ªæº¶æ¶²ïŒè©Šéšæ¶²ïŒ100ÎŒlãš
ã®æ··å液ã96ç©Žãã¬ãŒãã«å ¥ãã37âãïŒïŒ çé ž
ã¬ã¹æ··å空æ°ã®äžã§ãïŒæ¥éå¹é€ããã0.2ïŒ ã
ãããã«âããã©ãŸãªãŠã ïŒNBTãã·ã°ã瀟ïŒ
ã®æº¶æ¶²ïŒ0.2ÎŒgïŒmlTPAå«æå¹å°ã«æº¶ããã溶
液ïŒ100ÎŒlãå ããŠãããã«45åéå¹é€åŸãé¡åŸ®
é¡äžã§èŠ³å¯ãããéãæ²çããè²çŽ ãæãã现è
ãNBTéå èœéœæ§çŽ°èãšããŠèŠ³å¯ãããã
åçæ§çœè¡ç 现èïŒTHPâïŒïŒãããå骚é«æ§çœ
è¡ç 现èïŒHLâ60ïŒã37âãçé žã¬ã¹å¹é€åšäž
ã§ããããå¹é€ããå¢æ®æã«ãã现èããªã³é žç·©
è¡æ¶²ã§ããæŽæµããåŸãïŒïŒ çèå è¡æž ããã³
10nMãã¿ãã³ïŒ¡é žãæ·»å ããRPMIâ1640å¹å°
ïŒãã¿ãã³ãã¢ããé žåŒ·åïŒã«ãããããïŒÃ105
åïŒmlå¹å°ã«ãªãããã«æžæ¿ããã现èæžæ¿æ¶²
100ÎŒlãšçŽ°èååèªå°ç©è³ªæº¶æ¶²ïŒè©Šéšæ¶²ïŒ100ÎŒlãš
ã®æ··å液ã96ç©Žãã¬ãŒãã«å ¥ãã37âãïŒïŒ çé ž
ã¬ã¹æ··å空æ°ã®äžã§ãïŒæ¥éå¹é€ããã0.2ïŒ ã
ãããã«âããã©ãŸãªãŠã ïŒNBTãã·ã°ã瀟ïŒ
ã®æº¶æ¶²ïŒ0.2ÎŒgïŒmlTPAå«æå¹å°ã«æº¶ããã溶
液ïŒ100ÎŒlãå ããŠãããã«45åéå¹é€åŸãé¡åŸ®
é¡äžã§èŠ³å¯ãããéãæ²çããè²çŽ ãæãã现è
ãNBTéå èœéœæ§çŽ°èãšããŠèŠ³å¯ãããã
æ¬çºæã®çŽ°èååèªå°ç©è³ªãšïŒæ¥éå¹é€ããã
ãšã«ãããTHPâïŒçŽ°èãHLâ60现èã«NBT
éå èœãèªå°ãããã®ã¿ãªãããã©ããã¯ã¹ç²å
ã©ãé£èœãå¹é€å®¹åšå£ãžã®ä»çèœãé µæ¯è殺è
èœãé žæ§ãã¹ãã¢ã¿ãŒãŒæŽ»æ§ãβâã°ã«ã¯ããã
ãŒãŒæŽ»æ§ãªã©ãÎÏã®ç¹åŸŽãšããŠã现èéå®ã«åžž
çšãããïŒããããŠã¢ã« ãªã ãã¯ããã¢ãŒãž
ã¡ãœãããžãŒïŒManual of Macrophage
MethodologyïŒãããŒã»ã« ããã«ãŒç€Ÿãç±³åœã
1981幎ããå³è§£çœè¡çãéè³å ã1982幎ãïŒåçš®æ
æšã®æŽ»æ§ã®å¢åŒ·ãèªããããã
ãšã«ãããTHPâïŒçŽ°èãHLâ60现èã«NBT
éå èœãèªå°ãããã®ã¿ãªãããã©ããã¯ã¹ç²å
ã©ãé£èœãå¹é€å®¹åšå£ãžã®ä»çèœãé µæ¯è殺è
èœãé žæ§ãã¹ãã¢ã¿ãŒãŒæŽ»æ§ãβâã°ã«ã¯ããã
ãŒãŒæŽ»æ§ãªã©ãÎÏã®ç¹åŸŽãšããŠã现èéå®ã«åžž
çšãããïŒããããŠã¢ã« ãªã ãã¯ããã¢ãŒãž
ã¡ãœãããžãŒïŒManual of Macrophage
MethodologyïŒãããŒã»ã« ããã«ãŒç€Ÿãç±³åœã
1981幎ããå³è§£çœè¡çãéè³å ã1982幎ãïŒåçš®æ
æšã®æŽ»æ§ã®å¢åŒ·ãèªããããã
ãªãããããŸã§ã®èª¬æã§æãããªããã«ãæ¬çº
æã«ãªãæ°èŠçç掻æ§ç©è³ªã¯ãÎÏåé§çŽ°èã§ã
ãããããã³ããŠã¹ã®éªšé«æ§çœè¡ç 现èã«äœçšã
ãŠãÎÏæ§çŽ°èãžãšååãèªå°ããÎÏã«ç¹æãª
åçš®æ©èœã®æé²ãããããã溶液äžã§ã®ååéã
ããªãã¡ã²ã«ãéæã®ååéã50000±5000ã§ã
ããSDSâããªã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åã§ã®
ååéã50000±5000ã§ããããšãã³ã³ã«ãããª
ã³âãã¬ã³ãã«ã¬ãã³çã®ã¬ã¯ãã³ã«å¯ŸããŠçµ
åæ§ãæããããšãããæ¬çºæã®çŽ°èååèªå°ç©
質ã¯ããµãã»ãŠãããæ§é ãæããªãç³èçœè³ªã§
ãããšèããããã
æã«ãªãæ°èŠçç掻æ§ç©è³ªã¯ãÎÏåé§çŽ°èã§ã
ãããããã³ããŠã¹ã®éªšé«æ§çœè¡ç 现èã«äœçšã
ãŠãÎÏæ§çŽ°èãžãšååãèªå°ããÎÏã«ç¹æãª
åçš®æ©èœã®æé²ãããããã溶液äžã§ã®ååéã
ããªãã¡ã²ã«ãéæã®ååéã50000±5000ã§ã
ããSDSâããªã¢ã¯ãªã«ã¢ããã²ã«é»æ°æ³³åã§ã®
ååéã50000±5000ã§ããããšãã³ã³ã«ãããª
ã³âãã¬ã³ãã«ã¬ãã³çã®ã¬ã¯ãã³ã«å¯ŸããŠçµ
åæ§ãæããããšãããæ¬çºæã®çŽ°èååèªå°ç©
質ã¯ããµãã»ãŠãããæ§é ãæããªãç³èçœè³ªã§
ãããšèããããã
次ã«æ¬çºæã®çŽ°èååèªå°ç©è³ªã®è£œé æ¹æ³ã«ã€
ããŠè©³ããè¿°ã¹ãã
ããŠè©³ããè¿°ã¹ãã
æ¬çºæã§äœ¿çšããã现èã®å¹é€ã«ã¯ãé«çåç©
现èã®å¹é€ã«é©ããåçš®åæå¹å°ãçšããããã
代衚çãªå¹å°ãšããŠã¯ãäŸãã°RPMIâ1640å¹
å°ãã€ãŒã°ã«ã®MEMå¹å°ããã«ããã³å€æ³ã®
MEMå¹å°ãαâMEMå¹å°ãHamã®å¹å°ã199
å¹å°ãMcCoy5Aå¹å°ã scoveã®å¹å°ãªã©ã
åç¬ãããã¯é©å®æ··åããå¹å°ãçšãããããã
ããã®å¹å°ã®çµæã¯ã现èçµèå¹é€ãããŠã¢ã«ã
è¬è«ç€Ÿã1982幎ãã«èšèŒãããŠããããããã®å¹
å°ã«ã¯ãã¢ã«ããã³ãã€ã³ã·ãŠãªã³ããã©ã³ã¹ã
ãšãªã³ãªã©ã®è¡æž ç±æ¥ã®èçœè³ªãããè¡æž ãçè
å è¡æž ãçè¡æž ã銬è¡æž ãªã©ã®åç©è¡æž ãåç¬
ã§ããããã¯é©å®çµã¿åãããŠæ·»å ããŠãããã
ãŸãå¿ èŠã«å¿ããŠã埮çç©ã«ããæ±æãé²æ¢ãã
ããã«ãäŸãã°ããã·ãªã³10ã100åäœïŒmlå¹å°ã
ç¡«é žã¹ãã¬ãããã€ã·ã³10ã100ÎŒgïŒmlå¹å°ãç¡«
é žã«ããã€ã·ã³40ã60ÎŒgïŒmlå¹å°ãªã©ã®æçç©
質ãæ·»å ããããšãã§ãããå¹é€æ¶²ã®PHã®å¶åŸ¡
ããçé žã€ãªã³æ¿åºŠã®èª¿ç¯ã®ããã«ãäŸãã°10ã
60mMã®ããã¹ãïŒâïŒïŒâããããã·ãšãã«ïŒâ
ïŒâããã©ãžã³ãšã¿ã³ã¹ã«ãã³é žããªã©ã®PHç·©è¡
å€ã䜿çšããŠããããå¹é€å®¹åšã®æ質ã¯ç¹ã«éå®
ããã«äœ¿çšã§ãããã©ã¹ããã¯ãã¬ã©ã¹ãããã¯
éå±è£œã®ãã®ã§ãã€ãŠã现èã®å¢æ®ãå¯èœã§ãã
ã°ããã
现èã®å¹é€ã«é©ããåçš®åæå¹å°ãçšããããã
代衚çãªå¹å°ãšããŠã¯ãäŸãã°RPMIâ1640å¹
å°ãã€ãŒã°ã«ã®MEMå¹å°ããã«ããã³å€æ³ã®
MEMå¹å°ãαâMEMå¹å°ãHamã®å¹å°ã199
å¹å°ãMcCoy5Aå¹å°ã scoveã®å¹å°ãªã©ã
åç¬ãããã¯é©å®æ··åããå¹å°ãçšãããããã
ããã®å¹å°ã®çµæã¯ã现èçµèå¹é€ãããŠã¢ã«ã
è¬è«ç€Ÿã1982幎ãã«èšèŒãããŠããããããã®å¹
å°ã«ã¯ãã¢ã«ããã³ãã€ã³ã·ãŠãªã³ããã©ã³ã¹ã
ãšãªã³ãªã©ã®è¡æž ç±æ¥ã®èçœè³ªãããè¡æž ãçè
å è¡æž ãçè¡æž ã銬è¡æž ãªã©ã®åç©è¡æž ãåç¬
ã§ããããã¯é©å®çµã¿åãããŠæ·»å ããŠãããã
ãŸãå¿ èŠã«å¿ããŠã埮çç©ã«ããæ±æãé²æ¢ãã
ããã«ãäŸãã°ããã·ãªã³10ã100åäœïŒmlå¹å°ã
ç¡«é žã¹ãã¬ãããã€ã·ã³10ã100ÎŒgïŒmlå¹å°ãç¡«
é žã«ããã€ã·ã³40ã60ÎŒgïŒmlå¹å°ãªã©ã®æçç©
質ãæ·»å ããããšãã§ãããå¹é€æ¶²ã®PHã®å¶åŸ¡
ããçé žã€ãªã³æ¿åºŠã®èª¿ç¯ã®ããã«ãäŸãã°10ã
60mMã®ããã¹ãïŒâïŒïŒâããããã·ãšãã«ïŒâ
ïŒâããã©ãžã³ãšã¿ã³ã¹ã«ãã³é žããªã©ã®PHç·©è¡
å€ã䜿çšããŠããããå¹é€å®¹åšã®æ質ã¯ç¹ã«éå®
ããã«äœ¿çšã§ãããã©ã¹ããã¯ãã¬ã©ã¹ãããã¯
éå±è£œã®ãã®ã§ãã€ãŠã现èã®å¢æ®ãå¯èœã§ãã
ã°ããã
现èååèªå°ç©è³ªãç£çãããããã«ã¯ãé©åœ
ãªå¹å°ãçšããŠãããçœè¡ç 现èããå¹å°ïŒmlåœ
ããã«çŽïŒÃ105ãïŒÃ106åã奜ãŸããã¯ãçŽïŒ
Ã105ãïŒÃ106åãšãªãããã«æžæ¿ããå¹é€å®¹åš
ã«æ€ã蟌ãã次ãã§ãååèªå°èœãæããç©è³ª
ïŒååèªå°å€ïŒããã³ÎÏ掻æ§åç©è³ªãæ·»å ããã
现èãååèªå°å€åã³ÎÏ掻æ§åç©è³ªãå«ãå¹é€
容åšããå転æ°çŽ15ã40rpmã奜ãŸããã¯20ã
30rpmã«ãŠæ¹ã¯ããã€ã€ãçŽ35ã38âã奜ãŸãã
ã¯çŽ37âãçŽïŒã10ïŒ çé žã¬ã¹å«æ空æ°äžã湿床
çŽ90ã100ïŒ ã®æ¡ä»¶ã®äžã§ã40ã100æéæ¥çå¹é€
ããããšã«ããã现èååèªå°ç©è³ªãç£çããã
å¹é€äžæž äžã«æŸåºããããå¹å°ã®PHã¯ãå¹é€æé
äžçŽ6.0ã7.5ã«ç¶æããããšã奜ãŸããã
ãªå¹å°ãçšããŠãããçœè¡ç 现èããå¹å°ïŒmlåœ
ããã«çŽïŒÃ105ãïŒÃ106åã奜ãŸããã¯ãçŽïŒ
Ã105ãïŒÃ106åãšãªãããã«æžæ¿ããå¹é€å®¹åš
ã«æ€ã蟌ãã次ãã§ãååèªå°èœãæããç©è³ª
ïŒååèªå°å€ïŒããã³ÎÏ掻æ§åç©è³ªãæ·»å ããã
现èãååèªå°å€åã³ÎÏ掻æ§åç©è³ªãå«ãå¹é€
容åšããå転æ°çŽ15ã40rpmã奜ãŸããã¯20ã
30rpmã«ãŠæ¹ã¯ããã€ã€ãçŽ35ã38âã奜ãŸãã
ã¯çŽ37âãçŽïŒã10ïŒ çé žã¬ã¹å«æ空æ°äžã湿床
çŽ90ã100ïŒ ã®æ¡ä»¶ã®äžã§ã40ã100æéæ¥çå¹é€
ããããšã«ããã现èååèªå°ç©è³ªãç£çããã
å¹é€äžæž äžã«æŸåºããããå¹å°ã®PHã¯ãå¹é€æé
äžçŽ6.0ã7.5ã«ç¶æããããšã奜ãŸããã
次ã«å®æœäŸãæããŠãæ¬çºæãæŽã«å
·äœçã«èª¬
æããããæ¬çºæã¯ãããã«éå®ããããã®ã§ãª
ãããšã¯èšããŸã§ããªãããªã以äžã®èšèŒã«ãã
ãŠããïŒ ãã¯ç¹ã«èšèŒããªãéã容éããŒã»ã³ã
ïŒïŒ¶ïŒïŒ¶ïŒ ïŒãè¡šããããŸãç¹ã«èšèŒããªãéãã
å¹é€ã¯37âã湿床90ã100ïŒ ãïŒïŒ çé žã¬ã¹å«æ
空æ°äžã§è¡ãªã€ãã
æããããæ¬çºæã¯ãããã«éå®ããããã®ã§ãª
ãããšã¯èšããŸã§ããªãããªã以äžã®èšèŒã«ãã
ãŠããïŒ ãã¯ç¹ã«èšèŒããªãéã容éããŒã»ã³ã
ïŒïŒ¶ïŒïŒ¶ïŒ ïŒãè¡šããããŸãç¹ã«èšèŒããªãéãã
å¹é€ã¯37âã湿床90ã100ïŒ ãïŒïŒ çé žã¬ã¹å«æ
空æ°äžã§è¡ãªã€ãã
å®æœäŸ ïŒ
ããæ¥æ§åçæ§çœè¡ç
现èTHPâïŒçŽ°èããã
50åäœïŒmlã®ããã·ãªã³ãããã³50ÎŒgïŒmlã®ã¹
ãã¬ãããã€ã·ã³ãå«æããè¡æž ãå«ãŸãªã
RPMIâ1640å¹å°ã«ãŠã现èå¯åºŠïŒÃ105åïŒml
ãšãªãããã«çŽ°èæµ®é液ã調補ãããã®500mlã
çµç¹å¹é€çšã¹ãã³ããŒãã©ã¹ã³ã«æ€ã蟌ã¿ãåå
èªå°å€ãšããŠã12âïŒâããã©ãã«ãã€ã«ãã«ã
ãŒã«â13âã¢ã»ããŒãïŒTPAïŒãÎÏ掻æ§åç©è³ª
ãšããŠãã¿ãã³ïŒ¡é žïŒRAïŒããããã1ÎŒgïŒml
ãšãªãããã«æ·»å ããå転æ°30rpmã«ãŠæ¹ã¯ã
ãã37âãïŒïŒ çé žã¬ã¹å«æ空æ°äžã§72æéå¹é€
ããããã®åŸãã¹ãã³ããŒãã©ã¹ã³äžã®å¹é€äžæž
ãåéãã3000rpmã§10åéé å¿ãã现èå±ãé€
å»ããåŸãäžæž äžã®çŽ°èååèªå°ç©è³ªã®æŽ»æ§ã枬
å®ãããå³ã¡ãå¢æ®æã«ããÎâïŒçŽ°èïŒÃ
105cellsïŒmlïŒå¹å°ïŒã€ãŒã°ã«MEMïŒïŒå¹éã
ã¿ãã³ã»ã¢ããé žïŒ10ïŒ çèå è¡æž ïŒæµ®é液ã«åŸ
ãããå¹é€æ¶²ãæ··ãããã®ïŒmlã10mlã¬ã©ã¹ç®¡ã«
ãšãã暪ã«åããŠãçé žã¬ã¹å¹é€åšäžã§ã37âã§
ïŒæ¥éå¹é€åŸãé å¿åŠçïŒ1000rpmã10åéïŒã
æœããäžæŸã¿æ¶²ãæšãŠè¡æž ãå«ãŸãªãå¹é€æ¶²ïŒml
ãå ããŠåã³çŽ°èãæžæ¿ãã2ÎŒlïŒmlã®æ¿åºŠã®ã
ãªã¹ãã¬ã³ã»ã©ããã¯ã¹ç²åïŒ1.004ÎŒmïŒç©æ°Žå
åŠç€Ÿè£œïŒãå ãæ¹ã¯ãããåŸãããã«ïŒæéå¹é€
ããããã®çŽ°èããPBS1mlã§ããæŽæµãé å¿
ãã现èå€ã®ã©ããã¯ã¹ç²åãé€å»ããããã®æ
äœãïŒåç¹°ãè¿ããã®ã¡ãé å¿ç®¡ã®åºã«æ²æŸ±ãã
现èãããããã§åžãäžããã¹ã©ã€ãã¬ã©ã¹äžã«
ïŒæ»Žèœãšããããã«0.5ïŒ ãšãªã·ã³æ¶²ïŒæ»Žãå ãã
ã«ããŒã¬ã©ã¹ãã®ããé¡åŸ®é¡ã§èŠ³å¯ãããèµ€ãæ
è²ãããæ»çŽ°èãé€ããç现èã®ã¿ã«ã€ããŠãã©
ããã¯ã¹ç²åãã©ãé£ãã现èãšéã©ãé£çŽ°èãš
ãèšæ°ããã©ãé£çŽ°èã®æ¯çãæ±ãããå¹é€æ¶²ã
é©å®åžéããŠãäžèšã®æž¬å®ãè¡ãªããã©ãé£çŽ°è
ã®æ¯çã10ïŒ ã«ãªãã®ã«å¿ èŠãªãå¹é€æ¶²ã®åžéç
ã®éæ°ããã€ãŠãïŒåäœïŒïŒµïŒïŒmlãšå®çŸ©ããã
æ¬çºæã®çŽ°èååèªå°ç©è³ªã®æŽ»æ§éã¯ãåŸããã
å¹é€æ¶²ã«ãããŠã173åäœïŒmlã§ãã€ããåŸãã
ãå¹é€æ¶²ã®ã¬ã¯ãã³ã«ããããåžçæ§ãæ€èšã
ããåžè²©ã®åçš®ã¬ã¯ãã³åºå®åæš¹èãåžè²©ã»ãã³
ãŒã«ããã«ã©ã ïŒãã€ãªã©ãã瀟補ïŒã«å å¡«ã
150mMã®å¡©åãããªãŠã ãå«ã50mMãªã³é žç·©
è¡æ¶²ïŒPH7.5ïŒã§å åã«æŽæµåŸãå¹é€æ¶²è©Šæãæ·»
å ããåç·©è¡æ¶²ã«ãŠæŽæµãã次ãã§ãåçš®ç³é¡ã
å«ã溶é¢æ¶²ã§æº¶åºãè¡ãªã€ããã³ã³ã«ãããªã³â
ïŒConâïŒãããã³ãã¬ã³ãã«ã¬ã¯ãã³ã®ã«ã©
ã ãçšããå Žåã«ãã¬ã¯ãã³ã«ã©ã ãžã®åžçãèª
ãããããããã®ã«ã©ã ã«ãããŠã0.2Mαâã¡ã
ã«âïœâãã³ãã·ã溶液ã«ããã现èååèªå°æŽ»
æ§ã溶åºããã
50åäœïŒmlã®ããã·ãªã³ãããã³50ÎŒgïŒmlã®ã¹
ãã¬ãããã€ã·ã³ãå«æããè¡æž ãå«ãŸãªã
RPMIâ1640å¹å°ã«ãŠã现èå¯åºŠïŒÃ105åïŒml
ãšãªãããã«çŽ°èæµ®é液ã調補ãããã®500mlã
çµç¹å¹é€çšã¹ãã³ããŒãã©ã¹ã³ã«æ€ã蟌ã¿ãåå
èªå°å€ãšããŠã12âïŒâããã©ãã«ãã€ã«ãã«ã
ãŒã«â13âã¢ã»ããŒãïŒTPAïŒãÎÏ掻æ§åç©è³ª
ãšããŠãã¿ãã³ïŒ¡é žïŒRAïŒããããã1ÎŒgïŒml
ãšãªãããã«æ·»å ããå転æ°30rpmã«ãŠæ¹ã¯ã
ãã37âãïŒïŒ çé žã¬ã¹å«æ空æ°äžã§72æéå¹é€
ããããã®åŸãã¹ãã³ããŒãã©ã¹ã³äžã®å¹é€äžæž
ãåéãã3000rpmã§10åéé å¿ãã现èå±ãé€
å»ããåŸãäžæž äžã®çŽ°èååèªå°ç©è³ªã®æŽ»æ§ã枬
å®ãããå³ã¡ãå¢æ®æã«ããÎâïŒçŽ°èïŒÃ
105cellsïŒmlïŒå¹å°ïŒã€ãŒã°ã«MEMïŒïŒå¹éã
ã¿ãã³ã»ã¢ããé žïŒ10ïŒ çèå è¡æž ïŒæµ®é液ã«åŸ
ãããå¹é€æ¶²ãæ··ãããã®ïŒmlã10mlã¬ã©ã¹ç®¡ã«
ãšãã暪ã«åããŠãçé žã¬ã¹å¹é€åšäžã§ã37âã§
ïŒæ¥éå¹é€åŸãé å¿åŠçïŒ1000rpmã10åéïŒã
æœããäžæŸã¿æ¶²ãæšãŠè¡æž ãå«ãŸãªãå¹é€æ¶²ïŒml
ãå ããŠåã³çŽ°èãæžæ¿ãã2ÎŒlïŒmlã®æ¿åºŠã®ã
ãªã¹ãã¬ã³ã»ã©ããã¯ã¹ç²åïŒ1.004ÎŒmïŒç©æ°Žå
åŠç€Ÿè£œïŒãå ãæ¹ã¯ãããåŸãããã«ïŒæéå¹é€
ããããã®çŽ°èããPBS1mlã§ããæŽæµãé å¿
ãã现èå€ã®ã©ããã¯ã¹ç²åãé€å»ããããã®æ
äœãïŒåç¹°ãè¿ããã®ã¡ãé å¿ç®¡ã®åºã«æ²æŸ±ãã
现èãããããã§åžãäžããã¹ã©ã€ãã¬ã©ã¹äžã«
ïŒæ»Žèœãšããããã«0.5ïŒ ãšãªã·ã³æ¶²ïŒæ»Žãå ãã
ã«ããŒã¬ã©ã¹ãã®ããé¡åŸ®é¡ã§èŠ³å¯ãããèµ€ãæ
è²ãããæ»çŽ°èãé€ããç现èã®ã¿ã«ã€ããŠãã©
ããã¯ã¹ç²åãã©ãé£ãã现èãšéã©ãé£çŽ°èãš
ãèšæ°ããã©ãé£çŽ°èã®æ¯çãæ±ãããå¹é€æ¶²ã
é©å®åžéããŠãäžèšã®æž¬å®ãè¡ãªããã©ãé£çŽ°è
ã®æ¯çã10ïŒ ã«ãªãã®ã«å¿ èŠãªãå¹é€æ¶²ã®åžéç
ã®éæ°ããã€ãŠãïŒåäœïŒïŒµïŒïŒmlãšå®çŸ©ããã
æ¬çºæã®çŽ°èååèªå°ç©è³ªã®æŽ»æ§éã¯ãåŸããã
å¹é€æ¶²ã«ãããŠã173åäœïŒmlã§ãã€ããåŸãã
ãå¹é€æ¶²ã®ã¬ã¯ãã³ã«ããããåžçæ§ãæ€èšã
ããåžè²©ã®åçš®ã¬ã¯ãã³åºå®åæš¹èãåžè²©ã»ãã³
ãŒã«ããã«ã©ã ïŒãã€ãªã©ãã瀟補ïŒã«å å¡«ã
150mMã®å¡©åãããªãŠã ãå«ã50mMãªã³é žç·©
è¡æ¶²ïŒPH7.5ïŒã§å åã«æŽæµåŸãå¹é€æ¶²è©Šæãæ·»
å ããåç·©è¡æ¶²ã«ãŠæŽæµãã次ãã§ãåçš®ç³é¡ã
å«ã溶é¢æ¶²ã§æº¶åºãè¡ãªã€ããã³ã³ã«ãããªã³â
ïŒConâïŒãããã³ãã¬ã³ãã«ã¬ã¯ãã³ã®ã«ã©
ã ãçšããå Žåã«ãã¬ã¯ãã³ã«ã©ã ãžã®åžçãèª
ãããããããã®ã«ã©ã ã«ãããŠã0.2Mαâã¡ã
ã«âïœâãã³ãã·ã溶液ã«ããã现èååèªå°æŽ»
æ§ã溶åºããã
Conâã«ã©ã ã«åžçã溶åºãã现èååèªå°
掻æ§ã«ã€ããŠãååéãçé»ç¹ã®æž¬å®ãè¡ãªã€
ããååé枬å®ã®ããã該现èååèªå°ç©è³ªã®æŽ»
æ§ç»åãããã«ããã³ ãªã³é žç·©è¡æ¶²ïŒå¡©åã«ãª
ãŠã 0.2gïŒïœãå¡©åãããªãŠã 8gïŒïœããªã³é žç¬¬
ïŒã«ãªãŠã 0.2gïŒïœããªã³é žç¬¬ïŒãããªãŠã
1.15gïŒïœãPH7.4ïŒã«0.01ïŒ ããªãšãã¬ã³ã°ãªã³
ãŒã«ãæ·»å ãã溶液ã«ãŠå¹³è¡¡åããSuperose6ïŒ
Superose12ïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããã²ã«ã
éæ³ã«ããåç»ããÎâïŒçŽ°èã§ã®ã©ãé£èœã®èª
èµ·ã«ãã现èååèªå°æŽ»æ§ã枬å®ãããšãããå
åé50000±5000ã®ç»åã«çŽ°èååèªå°ç©è³ªã®æŽ»
æ§ãèªããããã
掻æ§ã«ã€ããŠãååéãçé»ç¹ã®æž¬å®ãè¡ãªã€
ããååé枬å®ã®ããã該现èååèªå°ç©è³ªã®æŽ»
æ§ç»åãããã«ããã³ ãªã³é žç·©è¡æ¶²ïŒå¡©åã«ãª
ãŠã 0.2gïŒïœãå¡©åãããªãŠã 8gïŒïœããªã³é žç¬¬
ïŒã«ãªãŠã 0.2gïŒïœããªã³é žç¬¬ïŒãããªãŠã
1.15gïŒïœãPH7.4ïŒã«0.01ïŒ ããªãšãã¬ã³ã°ãªã³
ãŒã«ãæ·»å ãã溶液ã«ãŠå¹³è¡¡åããSuperose6ïŒ
Superose12ïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããã²ã«ã
éæ³ã«ããåç»ããÎâïŒçŽ°èã§ã®ã©ãé£èœã®èª
èµ·ã«ãã现èååèªå°æŽ»æ§ã枬å®ãããšãããå
åé50000±5000ã®ç»åã«çŽ°èååèªå°ç©è³ªã®æŽ»
æ§ãèªããããã
SDSâããªã¢ã¯ãªã«ã¢ããé»æ°æ³³åæ³ã«ããå
åé枬å®ã®ãããããªã¹ïŒã°ãªã·ã³ïŒSDSïŒPH
8.3ïŒã§ãé»æ°æ³³åãè¡ãªã€ããæšæºååéãã
ãïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããŠååéæ€éç·ã
äœæããåç»ããã²ã«ããã®æœåºç©ã®ÎâïŒçŽ°è
ã®ã©ãé£èœèªèµ·æŽ»æ§è©äŸ¡ã«ããååéã決å®ãã
ãšãããååé50000±5000ã®ç»åã«çŽ°èååèª
å°ç©è³ªã®æŽ»æ§ãèªããããã
åé枬å®ã®ãããããªã¹ïŒã°ãªã·ã³ïŒSDSïŒPH
8.3ïŒã§ãé»æ°æ³³åãè¡ãªã€ããæšæºååéãã
ãïŒãã¢ã«ãã·ã¢ç€Ÿè£œïŒãçšããŠååéæ€éç·ã
äœæããåç»ããã²ã«ããã®æœåºç©ã®ÎâïŒçŽ°è
ã®ã©ãé£èœèªèµ·æŽ»æ§è©äŸ¡ã«ããååéã決å®ãã
ãšãããååé50000±5000ã®ç»åã«çŽ°èååèª
å°ç©è³ªã®æŽ»æ§ãèªããããã
çé»ç¹æž¬å®ã®ããã«ãçé»ç¹é»æ°æ³³åæ³ã以äž
ã®æ¹æ³ã«ãã€ãŠè¡ãªã€ããå³ã¡ãã¢ããŒæ ªåŒäŒç€Ÿ
補ã®çé»ç¹é»æ°æ³³åè£ çœ®ïŒSJ1071ECåïŒãçšãã
ãã¢ã«ãã©ã€ãïŒãã¢ã«ãã·ã¢ç€Ÿè£œãPHïŒãïŒïŒ
ãšã°ãªã»ããŒã«ãå«ãïŒïŒ ããªã¢ã¯ãªã«ã¢ããå¹³
æ¿ã²ã«ãäœæãããéœæ¥µåŽã«0.04M DLâã°ã«ã¿
ãã³é žãé°æ¥µåŽã«0.2M âãã¹ããžã³ã䜿çšã
ãŠã700Vã§50åéã®åæ³³åãè¡ãªã€ããç¶ããŠ
è©Šæãä»äžãã700Vã§ïŒæéã500Vã§16æéæ³³
åãè¡ãªã€ããæ³³åçµäºåŸã²ã«ã2.5mmå·Ÿã§åã
åºãã次ãã§åã²ã«çã0.15Må¡©åãããªãŠã ã
å«ã0.02Mããªã¹âå¡©é žç·©è¡æ¶²ïŒPH8.2ïŒ0.2mlã§
æœåºããåæœåºæ¶²ã«ã€ããŠãÎâïŒçŽ°èãçšãã
现èååèªå°æŽ»æ§ã®è©äŸ¡ãè¡ãªã€ããšãããçé»
ç¹ã¯PH6.5±1.0ã§ãã€ãã
ã®æ¹æ³ã«ãã€ãŠè¡ãªã€ããå³ã¡ãã¢ããŒæ ªåŒäŒç€Ÿ
補ã®çé»ç¹é»æ°æ³³åè£ çœ®ïŒSJ1071ECåïŒãçšãã
ãã¢ã«ãã©ã€ãïŒãã¢ã«ãã·ã¢ç€Ÿè£œãPHïŒãïŒïŒ
ãšã°ãªã»ããŒã«ãå«ãïŒïŒ ããªã¢ã¯ãªã«ã¢ããå¹³
æ¿ã²ã«ãäœæãããéœæ¥µåŽã«0.04M DLâã°ã«ã¿
ãã³é žãé°æ¥µåŽã«0.2M âãã¹ããžã³ã䜿çšã
ãŠã700Vã§50åéã®åæ³³åãè¡ãªã€ããç¶ããŠ
è©Šæãä»äžãã700Vã§ïŒæéã500Vã§16æéæ³³
åãè¡ãªã€ããæ³³åçµäºåŸã²ã«ã2.5mmå·Ÿã§åã
åºãã次ãã§åã²ã«çã0.15Må¡©åãããªãŠã ã
å«ã0.02Mããªã¹âå¡©é žç·©è¡æ¶²ïŒPH8.2ïŒ0.2mlã§
æœåºããåæœåºæ¶²ã«ã€ããŠãÎâïŒçŽ°èãçšãã
现èååèªå°æŽ»æ§ã®è©äŸ¡ãè¡ãªã€ããšãããçé»
ç¹ã¯PH6.5±1.0ã§ãã€ãã
次ã«ã现èååèªå°ç©è³ªã®ç±å®å®æ§ãæ€èšã
ããå¹é€æ¶²ã«ã0.01ïŒ ããªãšãã¬ã³ã°ãªã³ãŒã«ã
æ·»å ããPH7.4ãªã³é žç·©è¡æ¶²ã«ãŠïŒåã«åžéãã
æå®ã®æéãæå®ã®æž©åºŠã«ãŠå ç±ããåŸãÎâïŒ
现èãçšãã现èååèªå°æŽ»æ§ã®è©äŸ¡ãè¡ãªã€ã
ãšããã70âã®å ç±åŠçã«ãããŠããã®æŽ»æ§ãä¿
æããŠããã100âã15åã®å ç±ã«ããã倱掻ã
ãã
ããå¹é€æ¶²ã«ã0.01ïŒ ããªãšãã¬ã³ã°ãªã³ãŒã«ã
æ·»å ããPH7.4ãªã³é žç·©è¡æ¶²ã«ãŠïŒåã«åžéãã
æå®ã®æéãæå®ã®æž©åºŠã«ãŠå ç±ããåŸãÎâïŒ
现èãçšãã现èååèªå°æŽ»æ§ã®è©äŸ¡ãè¡ãªã€ã
ãšããã70âã®å ç±åŠçã«ãããŠããã®æŽ»æ§ãä¿
æããŠããã100âã15åã®å ç±ã«ããã倱掻ã
ãã
ãžã¹ã«ãã€ãçµåã®éå
å€ã«ãã圱é¿ãæ€èšã
ãããã«ããžããªã¹ã¬ã€ããŒã«ïŒDTTïŒãåã¯ã
ïŒâã¡ã«ã«ãããšã¿ããŒã«ïŒïŒâMEïŒããå¹é€
液äžã«å ãã37âã§ãïŒæéåå¿ããããåå¿
åŸãÎâïŒçŽ°èã«å¯Ÿããã©ãé£èœèªèµ·æŽ»æ§ã枬å®
ããã50mMã®DTTåŠçã«ããããã®æŽ»æ§ã倱
ã€ãã
ãããã«ããžããªã¹ã¬ã€ããŒã«ïŒDTTïŒãåã¯ã
ïŒâã¡ã«ã«ãããšã¿ããŒã«ïŒïŒâMEïŒããå¹é€
液äžã«å ãã37âã§ãïŒæéåå¿ããããåå¿
åŸãÎâïŒçŽ°èã«å¯Ÿããã©ãé£èœèªèµ·æŽ»æ§ã枬å®
ããã50mMã®DTTåŠçã«ããããã®æŽ»æ§ã倱
ã€ãã
PHå®å®æ§ã次ã«ç€ºãã现èååèªå°ç©è³ªãå«ã
å¹é€æ¶²ã«ãïŒåéã®PHïŒïŒïŒïŒ7.3ïŒïŒïŒ10ã®å
皮緩è¡æ¶²ãæ·»å ãã24æéã37âã«å æž©ããåŸã
PHãäžæ§ã«ãã©ããÎâïŒçŽ°èã«å¯Ÿãã现èåå
èªå°æŽ»æ§ã枬å®ãããPHïŒã10ã®ç¯å²ã®ãããã«
ãããŠã掻æ§ã®äœäžã¯èªããããªãã€ãã
å¹é€æ¶²ã«ãïŒåéã®PHïŒïŒïŒïŒ7.3ïŒïŒïŒ10ã®å
皮緩è¡æ¶²ãæ·»å ãã24æéã37âã«å æž©ããåŸã
PHãäžæ§ã«ãã©ããÎâïŒçŽ°èã«å¯Ÿãã现èåå
èªå°æŽ»æ§ã枬å®ãããPHïŒã10ã®ç¯å²ã®ãããã«
ãããŠã掻æ§ã®äœäžã¯èªããããªãã€ãã
ã€ãã§ãèçœå解é
µçŽ ã«å¯Ÿããå®å®æ§ãæ€èšã
ãã现èååèªå°ç©è³ªãå«ãå¹é€æ¶²ã«èçœåè§£é µ
çŽ ããªãã·ã³ããŸãã¯ãããããŒãŒâïŒ200å
äœïŒãæ·»å ãã37âã«ãŠãïŒæéåå¿ããããå
å¿åŸãÎâïŒçŽ°èã«å¯Ÿãã现èååèªå°æŽ»æ§ã枬
å®ãããããããã®æ¡ä»¶ã«ãããŠãã掻æ§ã®äœäž
ã¯èªããããªãã€ããäžèšå®éšã«0.1ïŒ SDSãæ·»
å ããããšä»¥å€ã¯ãåäžã®æ¡ä»¶ã«ãŠãèçœåè§£é µ
çŽ ã®å¹æãæ€èšãããšããã0.1ïŒ SDSã®æ·»å æ
ã®ããããŒãŒâã«ããã现èååèªå°æŽ»æ§ãå®
å šã«æ¶å€±ããã
ãã现èååèªå°ç©è³ªãå«ãå¹é€æ¶²ã«èçœåè§£é µ
çŽ ããªãã·ã³ããŸãã¯ãããããŒãŒâïŒ200å
äœïŒãæ·»å ãã37âã«ãŠãïŒæéåå¿ããããå
å¿åŸãÎâïŒçŽ°èã«å¯Ÿãã现èååèªå°æŽ»æ§ã枬
å®ãããããããã®æ¡ä»¶ã«ãããŠãã掻æ§ã®äœäž
ã¯èªããããªãã€ããäžèšå®éšã«0.1ïŒ SDSãæ·»
å ããããšä»¥å€ã¯ãåäžã®æ¡ä»¶ã«ãŠãèçœåè§£é µ
çŽ ã®å¹æãæ€èšãããšããã0.1ïŒ SDSã®æ·»å æ
ã®ããããŒãŒâã«ããã现èååèªå°æŽ»æ§ãå®
å šã«æ¶å€±ããã
ããã«ãããçœè¡ç
现èã«å¯Ÿããççäœçšã確
èªãã¹ããçèå è¡æž ã10ïŒ å«ãRPMIâ1640å¹
å°ã«ããåçæ§çœè¡ç 现èïŒTHPâïŒïŒãããå
骚é«æ§çœè¡ç 现èïŒHLâ60ïŒã37âãçé žã¬ã¹
å¹é€åšäžã§ããããå¹é€ããå¢æ®æã«ãã现èã
ãªã³é žç·©è¡æ¶²ã§ããæŽæµããåŸã10ïŒ çèå è¡æž
ããã³10nMãã¿ãã³ïŒ¡é žãæ·»å ããRPMIâ
1640å¹å°ïŒãã¿ãã³ãã¢ããé žåŒ·åïŒã«ãããã
ãïŒÃ10åïŒmlå¹å°ã«ãªãããã«æžæ¿ããã现è
æžæ¿æ¶²100ÎŒlãšå¹é€æ¶²100ÎŒlãšã®æ··å液ã96ç©Žãã¬
ãŒãã«å ¥ãã37âãïŒïŒ çé žã¬ã¹æ··å空æ°ã®äž
ã§ãïŒæ¥éå¹é€ããã0.2ïŒ ããããã«âããã©
ãŸãªãŠã ïŒNBTãã·ã°ã瀟ïŒã®æº¶æ¶²ïŒ0.2ÎŒgïŒml
TPAå«æå¹å°ïŒ100ÎŒlãå ããŠãæŽã«45åéå¹é€
äžåŸãé¡åŸ®é¡äžã§èŠ³å¯ãããéãæ²çããè²çŽ ã
æããNBTéå èœéœæ§çŽ°èããTHPâïŒçŽ°èã«
ãããŠ39ïŒ ãHLâ60现èã«ãããŠ34ïŒ ã«èŠ³å¯ã
ããã
èªãã¹ããçèå è¡æž ã10ïŒ å«ãRPMIâ1640å¹
å°ã«ããåçæ§çœè¡ç 现èïŒTHPâïŒïŒãããå
骚é«æ§çœè¡ç 现èïŒHLâ60ïŒã37âãçé žã¬ã¹
å¹é€åšäžã§ããããå¹é€ããå¢æ®æã«ãã现èã
ãªã³é žç·©è¡æ¶²ã§ããæŽæµããåŸã10ïŒ çèå è¡æž
ããã³10nMãã¿ãã³ïŒ¡é žãæ·»å ããRPMIâ
1640å¹å°ïŒãã¿ãã³ãã¢ããé žåŒ·åïŒã«ãããã
ãïŒÃ10åïŒmlå¹å°ã«ãªãããã«æžæ¿ããã现è
æžæ¿æ¶²100ÎŒlãšå¹é€æ¶²100ÎŒlãšã®æ··å液ã96ç©Žãã¬
ãŒãã«å ¥ãã37âãïŒïŒ çé žã¬ã¹æ··å空æ°ã®äž
ã§ãïŒæ¥éå¹é€ããã0.2ïŒ ããããã«âããã©
ãŸãªãŠã ïŒNBTãã·ã°ã瀟ïŒã®æº¶æ¶²ïŒ0.2ÎŒgïŒml
TPAå«æå¹å°ïŒ100ÎŒlãå ããŠãæŽã«45åéå¹é€
äžåŸãé¡åŸ®é¡äžã§èŠ³å¯ãããéãæ²çããè²çŽ ã
æããNBTéå èœéœæ§çŽ°èããTHPâïŒçŽ°èã«
ãããŠ39ïŒ ãHLâ60现èã«ãããŠ34ïŒ ã«èŠ³å¯ã
ããã
以äžè©³çŽ°ã«èª¬æãããæ¬çºæã®çŽ°èååèªå°ç©
質ãå»è¬å補é ã®åžžå¥æ段ãäŸãã°å ç±åŠçãã
éæ» èãåçµä¹Ÿç¥ãå泚çã®åŠçãé©å®æœããŠè£œ
å€åããããšã«ãããåŸæ¥ã«ãªãæ°ããå»è¬åã
åŸãããšãã§ããã
質ãå»è¬å補é ã®åžžå¥æ段ãäŸãã°å ç±åŠçãã
éæ» èãåçµä¹Ÿç¥ãå泚çã®åŠçãé©å®æœããŠè£œ
å€åããããšã«ãããåŸæ¥ã«ãªãæ°ããå»è¬åã
åŸãããšãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ãã¯ããã¢ãŒãžæ§çŽ°èã«ååãããããçœè¡
ç 现èããååèªå°èœãæããç©è³ªããã³ãã¯ã
ãã¢ãŒãžæŽ»æ§åç©è³ªã®ååšäžã«æ¹æå¹é€ããããš
ãç¹åŸŽãšãããäžèšã®ç¹æ§ãæããçœè¡ç 现èã«
察ããŠçŽ°èååèªå°æŽ»æ§ãæããããç±æ¥çç掻
æ§ç©è³ªã®çç£æ³ã ïœ ååé 50000±5000ïŒã²ã«æ¿Ÿéæ³ïŒã 50000±5000ïŒSDSâããªã¢ã¯ãªã«ã¢ããé»æ°
æ³³åæ³ïŒã ïœ ã¬ã¯ãã³ã«ã©ã ãžã®åžçæ§ ã¬ã³ãã«ã¬ã¯ã
ã³ã«ã©ã ãã³ã³ã«ãããªã³ïŒ¡ã«ã©ã ã«åžçã
ãã ïœ ç±å®å®æ§ 70âïŒæéã§å€±æŽ»ããªãã ïœ éå å€ã«ããåœ±é¿ æŽ»æ§ãäœäžããã ïœ PHå®å®æ§ PHïŒã10ã®ç¯å²ã§å®å®ã§ããã
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27648086A JPS63129994A (ja) | 1986-11-21 | 1986-11-21 | ããç±æ¥çç掻æ§ç©è³ªã®è£œé æ³ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27648086A JPS63129994A (ja) | 1986-11-21 | 1986-11-21 | ããç±æ¥çç掻æ§ç©è³ªã®è£œé æ³ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63129994A JPS63129994A (ja) | 1988-06-02 |
| JPH0348798B2 true JPH0348798B2 (ja) | 1991-07-25 |
Family
ID=17570039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27648086A Granted JPS63129994A (ja) | 1986-11-21 | 1986-11-21 | ããç±æ¥çç掻æ§ç©è³ªã®è£œé æ³ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63129994A (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63130600A (ja) * | 1986-11-21 | 1988-06-02 | Agency Of Ind Science & Technol | çç掻æ§ç©è³ª |
| JPS63129993A (ja) * | 1986-11-21 | 1988-06-02 | Agency Of Ind Science & Technol | ããç±æ¥çç掻æ§ç©è³ªã®è£œé æ¹æ³ |
| FR2673195B1 (fr) * | 1991-02-25 | 1994-09-02 | Inst Nat Sante Rech Med | Cultures de lignees permanentes de cellules promyelocytaires humaines, et leurs utilisations pour le criblage de molecules utilisables notamment dans le traitement des leucemies. |
| JP5513802B2 (ja) * | 2009-08-04 | 2014-06-04 | ããŒãŠãŒæ ªåŒäŒç€Ÿ | çé»ç¹é»æ°æ³³åçšã²ã«åã³çé»ç¹é»æ°æ³³åæ¹æ³ |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6028934A (ja) * | 1983-07-25 | 1985-02-14 | Green Cross Corp:The | 现èååèªå°ç©è³ª |
| JPS63130600A (ja) * | 1986-11-21 | 1988-06-02 | Agency Of Ind Science & Technol | çç掻æ§ç©è³ª |
| JPS63129993A (ja) * | 1986-11-21 | 1988-06-02 | Agency Of Ind Science & Technol | ããç±æ¥çç掻æ§ç©è³ªã®è£œé æ¹æ³ |
-
1986
- 1986-11-21 JP JP27648086A patent/JPS63129994A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6028934A (ja) * | 1983-07-25 | 1985-02-14 | Green Cross Corp:The | 现èååèªå°ç©è³ª |
| JPS63130600A (ja) * | 1986-11-21 | 1988-06-02 | Agency Of Ind Science & Technol | çç掻æ§ç©è³ª |
| JPS63129993A (ja) * | 1986-11-21 | 1988-06-02 | Agency Of Ind Science & Technol | ããç±æ¥çç掻æ§ç©è³ªã®è£œé æ¹æ³ |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63129994A (ja) | 1988-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4342828A (en) | Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells | |
| Glenn et al. | Human monocyte-derived growth factor (s) for mesenchymal cells: activation of secretion by endotoxin and concanavalin A | |
| Fischer | Tissue culture; studies in experimental morphology and general physiology of tissue cells in vitro | |
| US3686395A (en) | Process for preparation of storage stable hepatitis-free serum | |
| Avis et al. | Cellular constituents. The chemistry of xanthine oxidase. Part I. The preparation of a crystalline xanthine oxidase from cow's milk | |
| JPH04501429A (ja) | ãŠã€ã«ã¹ã§æ±æãããè¬ççµæç©äžã®ãŠã€ã«ã¹ã®äžæŽ»æ§åæ¹æ³ | |
| US4473647A (en) | Tissue culture medium | |
| Buescher et al. | Abnormal adherence-related functions of neutrophils, monocytes, and Epstein-Barr virus-transformed B cells in a patient with C3bi receptor deficiency | |
| CN110150384A (zh) | ä¹³éèçœç²åå ¶å¶å€æ¹æ³ | |
| JPH0348798B2 (ja) | ||
| JPH0348797B2 (ja) | ||
| Green et al. | Inhibition of mumps virus multiplication by a synthetic polypeptide | |
| US4760021A (en) | Biological response modifier having cell differentiation-induction activity and process for production thereof | |
| JPH0474360B2 (ja) | ||
| JPS63126897A (ja) | å ç«æå¶å å | |
| EP0048283A1 (en) | Virus-inhibiting substance and process for preparing the same | |
| AU643061B2 (en) | Human cytosolic phospholipase A2 | |
| JPS6030688A (ja) | ããçå£æ»å åã®è£œé æ³ | |
| JPS6028935A (ja) | æ°èŠããæäœç£çå¢åŒ·å åããã³ãã®è£œé æ³ | |
| Emery | The metabolism of aminoâacids by Paramecium caudatum | |
| Evans | THE TOXICITY OF ACIDS FOR LEUCOCYTES, AS INDICATED BY THE TROPIN REACTION¹ | |
| JPH02100696A (ja) | ããç±æ¥ååèªå°ç©è³ª | |
| JPH03505200A (ja) | æ²»ç掻æ§ã®ãããç¹ã«å·æ²»çãŸãã¯è人å»åŠã«çšããäœçšç©è³ªããã³ãããäœçšç©è³ªãå«ã補å€ã®è£œé æ¹æ³ | |
| Maslow et al. | The effects of tumour cells on embryonic cell aggregation, adhesion and detachment | |
| RU2128513C1 (ru) | СпПÑПб пПлÑÑÐµÐœÐžÑ Ð»ÐµÑебМПгП ÑÑеЎÑÑва, ÑегÑлОÑÑÑÑегП ЎОÑÑеÑеМÑОаÑÐžÑ ÐºÐ»ÐµÑкО |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |